{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:15:08Z","timestamp":1783649708425,"version":"3.55.0"},"reference-count":297,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["20-65-FENG"],"award-info":[{"award-number":["20-65-FENG"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R44CA176937"],"award-info":[{"award-number":["R44CA176937"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R44CA176937"],"award-info":[{"award-number":["R44CA176937"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA237027"],"award-info":[{"award-number":["R01CA237027"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA251198"],"award-info":[{"award-number":["R01CA251198"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA250412"],"award-info":[{"award-number":["R01CA250412"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Growing evidence has revealed that DEAD-box RNA helicase 5 (DDX5, also known as p68) and ubiquitin-conjugating enzyme E2T (UbE2T) are two emerging and highly promising cancer therapeutic targets. This article provides the first comprehensive review of the physical and functional relationship between these two cancer targets, further refining their therapeutic potentials in solid cancers. In addition, the consequences of simultaneously degrading DDX5 and UbE2T proteins by the small-molecule dual molecular glue degrader FL118 in difficult-to-treat advanced cancers are presented.<\/jats:p>\n                  <jats:p>Specifically, this article reviews: (1) the roles of DDX5 and UbE2T in diverse cancer DNA repair pathways; (2) the physical binding relationship and potential functional roles of DDX5 in topoisomerase regulation; (3) the involvement of DDX5 in EZH2- and NANOG-associated prostate cancer stem cell (PCSC)\u2013driven neuroendocrine prostate cancer (NEPC), castration-resistant prostate cancer (CRPC), and metastatic CRPC (mCRPC); (4) the contributions of DDX5 and UbE2T to inflammatory and immune regulation within the tumor microenvironment (TME); (5) FL118 as a small-molecule dual molecular glue degrader selectively targeting both DDX5 and UbE2T; (6) the high efficacy of FL118 against multiple difficult-to-treat advanced and metastatic cancers, including advanced colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), osteosarcoma, Ewing sarcoma, ovarian cancer, and glioma\/glioblastoma; (7) the resistance of ABCG2-expressing cancer cells to common anticancer agents but not to FL118; (8) the favorable pharmacokinetic and toxicology profiles of FL118 in mice, rats, and dogs; (9) the distinct functions of DDX5 in normal tissues, cells, and organs versus cancer; and (10) FL118 as a drug platform enabling the development of novel analogs and derivatives.<\/jats:p>\n                  <jats:p>Based on this review, we conclude that DDX5 and UbE2T represent superior anticancer therapeutic targets, and that the high efficacy of FL118 against multiple difficult-to-treat cancers is attributable to its function as a bona fide small-molecule dual molecular glue degrader that physically targets and degrades both DDX5 and UbE2T. Strikingly, this activity is observed regardless of the expression status of ABC transporter proteins, ABCG2\/BCRP, ABCB1\/Pgp\/MDR1, and\/or ABCC1\/MRP1 in cancer cells.<\/jats:p>","DOI":"10.1186\/s13046-026-03733-3","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:25:53Z","timestamp":1779125153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers"],"prefix":"10.1186","volume":"45","author":[{"given":"Fengzhi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayan","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean G.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Sule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Vadehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Twist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Ohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkamal","family":"Chatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott I.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"1","key":"3733_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13046-023-02787-x","volume":"42","author":"F Li","year":"2023","unstructured":"Li F, Ling X, Chakraborty S, Fountzilas C, Wang J, Jamroze A, et al. Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence. J Exp Clin Cancer Res. 2023;42(1):213.","journal-title":"J Exp Clin Cancer Res"},{"key":"3733_CR2","doi-asserted-by":"crossref","unstructured":"Xie H, Zhang K, Yin H, Zhang S, Pan S, Wu R et al. Acetyltransferase NAT10 inhibits T-cell immunity and promotes nasopharyngeal carcinoma progression through DDX5\/HMGB1 axis. J Immunother Cancer. 2025;13(2):e010301.","DOI":"10.1136\/jitc-2024-010301"},{"issue":"12","key":"3733_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41419-023-06115-1","volume":"14","author":"W Tian","year":"2023","unstructured":"Tian W, Tang Y, Luo Y, Xie J, Zheng S, Zou Y, et al. AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Cell Death Dis. 2023;14(12):790.","journal-title":"Cell Death Dis"},{"key":"3733_CR4","doi-asserted-by":"crossref","unstructured":"Shi Y, Wang J, Yuan Q, Chen Y, Zhao M, Li X et al. DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability. Oncogene. 2024;43(44):3240\u201354.","DOI":"10.1038\/s41388-024-03162-6"},{"key":"3733_CR5","unstructured":"Takenouchi S, Mitobe Y, Suzuki S, Nakagawa-Saito Y, Nakamura K, Ito Y et al. Ferroptosis defence mediated by stem cell-specific overexpression of DDX5 is a targetable vulnerability unique to glioma stem cells. Nat Progress Oncol. 2026."},{"issue":"1","key":"3733_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cells14010015","volume":"14","author":"C Gao","year":"2024","unstructured":"Gao C, Liu YJ, Yu J, Wang R, Shi JJ, Chen RY, et al. Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review. Cells. 2024;14(1):15.","journal-title":"Cells"},{"key":"3733_CR7","doi-asserted-by":"crossref","unstructured":"Wang K, He Q, Jiang X, Ma Y, Wang T, Zhou H et al. Biological Functions and Therapeutic Potential of UBE2T in Human Cancer. Curr Cancer Drug Targets. 2025.","DOI":"10.2174\/0115680096370867250211070948"},{"issue":"10","key":"3733_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41580-023-00628-5","volume":"24","author":"KE Bohnsack","year":"2023","unstructured":"Bohnsack KE, Yi S, Venus S, Jankowsky E, Bohnsack MT. Cellular functions of eukaryotic RNA helicases and their links to human diseases. Nat Rev Mol Cell Biol. 2023;24(10):749\u201369.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7267","key":"3733_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071\u20138.","journal-title":"Nature"},{"issue":"5","key":"3733_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41580-020-0218-z","volume":"21","author":"M Tarsounas","year":"2020","unstructured":"Tarsounas M, Sung P. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication. Nat Rev Mol Cell Biol. 2020;21(5):284\u201399.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"3733_CR11","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1093\/nar\/gkab178","volume":"49","author":"M San Martin Alonso","year":"2021","unstructured":"San Martin Alonso M, Noordermeer SM. Untangling the crosstalk between BRCA1 and R-loops during DNA repair. Nucleic Acids Res. 2021;49(9):4848\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"25","key":"3733_CR12","first-page":"00112","volume":"S0962\u20138924","author":"D Zong","year":"2025","unstructured":"Zong D, Pavani R, Nussenzweig A. New twist on BRCA1-mediated DNA recombination repair and tumor suppression. Trends Cell Biol. 2025;S0962\u20138924(25):00112\u20136.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"3733_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1083\/jcb.201110008","volume":"197","author":"S Kawai","year":"2012","unstructured":"Kawai S, Amano A. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J Cell Biol. 2012;197(2):201\u20138.","journal-title":"J Cell Biol"},{"issue":"9","key":"3733_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrc3107","volume":"11","author":"M van Kouwenhove","year":"2011","unstructured":"van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11(9):644\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"3733_CR15","doi-asserted-by":"publisher","first-page":"110127","DOI":"10.1016\/j.celrep.2021.110127","volume":"37","author":"Y Li","year":"2021","unstructured":"Li Y, Xing Y, Wang X, Hu B, Zhao X, Zhang H, et al. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer. Cell Rep. 2021;37(12):110127.","journal-title":"Cell Rep"},{"issue":"1","key":"3733_CR16","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-023-37578-7","volume":"14","author":"D Dattilo","year":"2023","unstructured":"Dattilo D, Di Timoteo G, Setti A, Giuliani A, Peruzzi G, Beltran Nebot M, et al. The m(6)A reader YTHDC1 and the RNA helicase DDX5 control the production of rhabdomyosarcoma-enriched circRNAs. Nat Commun. 2023;14(1):1898.","journal-title":"Nat Commun"},{"issue":"7","key":"3733_CR17","doi-asserted-by":"publisher","first-page":"e106018","DOI":"10.15252\/embj.2020106018","volume":"40","author":"G Sessa","year":"2021","unstructured":"Sessa G, Gomez-Gonzalez B, Silva S, Perez-Calero C, Beaurepere R, Barroso S, et al. BRCA2 promotes DNA-RNA hybrid resolution by DDX5 helicase at DNA breaks to facilitate their repairdouble dagger. EMBO J. 2021;40(7):e106018.","journal-title":"EMBO J"},{"issue":"1","key":"3733_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-019-1100-5","volume":"18","author":"L Bian","year":"2019","unstructured":"Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Mol Cancer. 2019;18(1):169.","journal-title":"Mol Cancer"},{"issue":"1","key":"3733_CR19","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1038\/s41467-019-09972-7","volume":"10","author":"JMD Legrand","year":"2019","unstructured":"Legrand JMD, Chan AL, La HM, Rossello FJ, Anko ML, Fuller-Pace FV, et al. DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia. Nat Commun. 2019;10(1):2278.","journal-title":"Nat Commun"},{"issue":"3","key":"3733_CR20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1021\/acs.jproteome.8b00771","volume":"18","author":"S Abbasi","year":"2019","unstructured":"Abbasi S, Schild-Poulter C. Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. J Proteome Res. 2019;18(3):1064\u201377.","journal-title":"J Proteome Res"},{"issue":"2","key":"3733_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ymthe.2022.08.005","volume":"31","author":"TK Le","year":"2023","unstructured":"Le TK, Cherif C, Omabe K, Paris C, Lannes F, Audebert S, et al. DDX5 mRNA-targeting Antisense Oligonucleotide as a new promising therapeutic in combating Castration-Resistant Prostate Cancer. Mol Ther. 2023;31(2):471\u201386.","journal-title":"Mol Ther"},{"issue":"8","key":"3733_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","volume":"18","author":"HHY Chang","year":"2017","unstructured":"Chang HHY, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol. 2017;18(8):495\u2013506.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3733_CR23","doi-asserted-by":"crossref","unstructured":"Zahid S, Seif El Dahan M, Iehl F, Fernandez-Varela P, Le Du MH, Ropars V et al. The Multifaceted Roles of Ku70\/80. Int J Mol Sci. 2021;22(8):4134.","DOI":"10.3390\/ijms22084134"},{"issue":"20","key":"3733_CR24","doi-asserted-by":"publisher","first-page":"11600","DOI":"10.1093\/nar\/gkac948","volume":"50","author":"T Mosler","year":"2022","unstructured":"Mosler T, Baymaz HI, Graf JF, Mikicic I, Blattner G, Bartlett E, et al. PARP1 proximity proteomics reveals interaction partners at stressed replication forks. Nucleic Acids Res. 2022;50(20):11600\u201318.","journal-title":"Nucleic Acids Res"},{"key":"3733_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1741-7015-10-25","volume":"10","author":"S Kummar","year":"2012","unstructured":"Kummar S, Chen A, Parchment RE, Kinders RJ, Ji J, Tomaszewski JE, et al. Advances in using PARP inhibitors to treat cancer. BMC Med. 2012;10:25.","journal-title":"BMC Med"},{"issue":"5","key":"3733_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrd1718","volume":"4","author":"P Jagtap","year":"2005","unstructured":"Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov. 2005;4(5):421\u201340.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"3733_CR27","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrm.2017.53","volume":"18","author":"A Ray Chaudhuri","year":"2017","unstructured":"Ray Chaudhuri A, Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017;18(10):610\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"3733_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrg2380","volume":"9","author":"KW Caldecott","year":"2008","unstructured":"Caldecott KW. Single-strand break repair and genetic disease. Nat Rev Genet. 2008;9(8):619\u201331.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"3733_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1101\/gad.291518.116","volume":"31","author":"R Gupte","year":"2017","unstructured":"Gupte R, Liu Z, Kraus WL. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev. 2017;31(2):101\u201326.","journal-title":"Genes Dev"},{"issue":"9","key":"3733_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tcb.2022.04.010","volume":"32","author":"KW Caldecott","year":"2022","unstructured":"Caldecott KW. DNA single-strand break repair and human genetic disease. Trends Cell Biol. 2022;32(9):733\u201345.","journal-title":"Trends Cell Biol"},{"issue":"6330","key":"3733_CR31","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A. PARP inhibitors: Synthetic lethality in the clinic. Science. 2017;355(6330):1152\u20138.","journal-title":"Science"},{"key":"3733_CR32","doi-asserted-by":"publisher","first-page":"106358","DOI":"10.1016\/j.biocel.2022.106358","volume":"155","author":"K Chen","year":"2023","unstructured":"Chen K, Dai M, Luo Q, Wang Y, Shen W, Liao Y, et al. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer. Int J Biochem Cell Biol. 2023;155:106358.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"3733_CR33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41467-017-00842-8","volume":"8","author":"G Antoniali","year":"2017","unstructured":"Antoniali G, Serra F, Lirussi L, Tanaka M, D\u2019Ambrosio C, Zhang S, et al. Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. Nat Commun. 2017;8(1):797.","journal-title":"Nat Commun"},{"key":"3733_CR34","doi-asserted-by":"crossref","unstructured":"Malfatti MC, Bellina A, Antoniali G, Tell G. Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons. Cells. 2023;12(14):1895.","DOI":"10.3390\/cells12141895"},{"issue":"1","key":"3733_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11033-023-08946-9","volume":"51","author":"PB Siqueira","year":"2024","unstructured":"Siqueira PB, de Sousa Rodrigues MM, de Amorim ISS, da Silva TG, da Silva Oliveira M, Rodrigues JA, et al. The APE1\/REF-1 and the hallmarks of cancer. Mol Biol Rep. 2024;51(1):47.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"3733_CR36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1158\/0008-5472.CAN-20-1010","volume":"81","author":"Y Hu","year":"2021","unstructured":"Hu Y, Yang C, Amorim T, Maqbool M, Lin J, Li C, et al. Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury. Cancer Res. 2021;81(3):713\u201323.","journal-title":"Cancer Res"},{"key":"3733_CR37","doi-asserted-by":"publisher","first-page":"738502","DOI":"10.3389\/fcell.2021.738502","volume":"9","author":"MA Hossain","year":"2021","unstructured":"Hossain MA, Lin Y, Driscoll G, Li J, McMahon A, Matos J, et al. APE2 Is a General Regulator of the ATR-Chk1 DNA Damage Response Pathway to Maintain Genome Integrity in Pancreatic Cancer Cells. Front Cell Dev Biol. 2021;9:738502.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3733_CR38","doi-asserted-by":"publisher","first-page":"zcad006","DOI":"10.1093\/narcan\/zcad006","volume":"5","author":"A McMahon","year":"2023","unstructured":"McMahon A, Zhao J, Yan S. APE2: catalytic function and synthetic lethality draw attention as a cancer therapy target. NAR Cancer. 2023;5(1):zcad006.","journal-title":"NAR Cancer"},{"issue":"1","key":"3733_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/cr.2008.6","volume":"18","author":"M Fousteri","year":"2008","unstructured":"Fousteri M, Mullenders LH. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 2008;18(1):73\u201384.","journal-title":"Cell Res"},{"issue":"7","key":"3733_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrm3822","volume":"15","author":"JA Marteijn","year":"2014","unstructured":"Marteijn JA, Lans H, Vermeulen W, Hoeijmakers JH. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol. 2014;15(7):465\u201381.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"3733_CR41","doi-asserted-by":"publisher","first-page":"e881","DOI":"10.1002\/ctm2.881","volume":"12","author":"X Ling","year":"2022","unstructured":"Ling X, Wu W, Aljahdali IAM, Liao J, Santha S, Fountzilas C, et al. FL118, acting as a \u2018molecular glue degrader\u2019, binds to, dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy. Clin translational Med. 2022;12(5):e881.","journal-title":"Clin translational Med"},{"issue":"8","key":"3733_CR42","first-page":"3676","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang J, Liu Z, Zhang D, Liu R, Lin Q, Liu J, et al. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties. Am J Transl Res. 2017;9(8):3676\u201386.","journal-title":"Am J Transl Res"},{"issue":"10","key":"3733_CR43","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1056\/NEJMoa060570","volume":"355","author":"KA Olaussen","year":"2006","unstructured":"Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med. 2006;355(10):983\u201391.","journal-title":"N Engl J Med"},{"key":"3733_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.critrevonc.2017.10.012","volume":"120","author":"Y Urun","year":"2017","unstructured":"Urun Y, Leow JJ, Fay AP, Albiges L, Choueiri TK, Bellmunt J. ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;120:120\u20136.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3733_CR45","doi-asserted-by":"crossref","unstructured":"Huang MY, Huang YJ, Cheng TL, Jhang WY, Ke CC, Chen YT et al. XPF-ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer. Cells. 2023;12(11):1475.","DOI":"10.3390\/cells12111475"},{"issue":"1","key":"3733_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13046-018-0899-8","volume":"37","author":"X Ling","year":"2018","unstructured":"Ling X, Wu W, Fan C, Xu C, Liao J, Rich LJ, et al. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res. 2018;37(1):240.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"3733_CR47","doi-asserted-by":"publisher","first-page":"e0128558","DOI":"10.1371\/journal.pone.0128558","volume":"10","author":"S Nicolai","year":"2015","unstructured":"Nicolai S, Filippi S, Caputo M, Cipak L, Gregan J, Ammerer G, et al. Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics. PLoS ONE. 2015;10(6):e0128558.","journal-title":"PLoS ONE"},{"key":"3733_CR48","doi-asserted-by":"crossref","unstructured":"Bilkis R, Lake RJ, Fan HY. ATP-Dependent Chromatin Remodeler CSB Couples DNA Repair Pathways to Transcription with Implications for Cockayne Syndrome and Cancer Therapy. Cells. 2025;14(4):239.","DOI":"10.3390\/cells14040239"},{"issue":"1\u20132","key":"3733_CR49","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cell.2014.12.031","volume":"160","author":"AT Wang","year":"2015","unstructured":"Wang AT, Smogorzewska A, SnapShot. Fanconi anemia and associated proteins. Cell. 2015;160(1\u20132):354\u2013e1.","journal-title":"Cell"},{"key":"3733_CR50","doi-asserted-by":"crossref","unstructured":"Parsa FG, Nobili S, Karimpour M, Aghdaei HA, Nazemalhosseini-Mojarad E, Mini E. Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy. J Pers Med. 2022;12(3):396.","DOI":"10.3390\/jpm12030396"},{"issue":"20","key":"3733_CR51","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1158\/0008-5472.CAN-23-2738","volume":"84","author":"YZ Huang","year":"2024","unstructured":"Huang YZ, Sang MY, Xi PW, Xu RX, Cai MY, Wang ZW, et al. FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer. Cancer Res. 2024;84(20):3447\u201363.","journal-title":"Cancer Res"},{"issue":"51","key":"3733_CR52","doi-asserted-by":"publisher","first-page":"e27690","DOI":"10.1097\/MD.0000000000027690","volume":"100","author":"X Liu","year":"2021","unstructured":"Liu X, Liu X, Han X. FANCI may serve as a prognostic biomarker for cervical cancer: A systematic review and meta-analysis. Med (Baltim). 2021;100(51):e27690.","journal-title":"Med (Baltim)"},{"issue":"6","key":"3733_CR53","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford AN, Jackson SP, ATM, ATR. The Trinity at the Heart of the DNA Damage Response. Mol Cell. 2017;66(6):801\u201317.","journal-title":"Mol Cell"},{"issue":"10","key":"3733_CR54","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1161\/CIRCRESAHA.119.314062","volume":"124","author":"Y Fan","year":"2019","unstructured":"Fan Y, Chen Y, Zhang J, Yang F, Hu Y, Zhang L, et al. Protective Role of RNA Helicase DEAD-Box Protein 5 in Smooth Muscle Cell Proliferation and Vascular Remodeling. Circ Res. 2019;124(10):e84\u2013100.","journal-title":"Circ Res"},{"issue":"3","key":"3733_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1158\/1541-7786.MCR-22-0399","volume":"21","author":"TE Bass","year":"2023","unstructured":"Bass TE, Fleenor DE, Burrell PE, Kastan MB. ATM Regulation of the Cohesin Complex Is Required for Repression of DNA Replication and Transcription in the Vicinity of DNA Double-Strand Breaks. Mol Cancer Res. 2023;21(3):261\u201373.","journal-title":"Mol Cancer Res"},{"issue":"5","key":"3733_CR56","doi-asserted-by":"publisher","first-page":"e0047521","DOI":"10.1128\/mcb.00475-21","volume":"42","author":"B Kayyar","year":"2022","unstructured":"Kayyar B, Ravikkumar AC, Bhaduri U, Rao MRS. Regulation of Sox8 through lncRNA Mrhl-Mediated Chromatin Looping in Mouse Spermatogonia. Mol Cell Biol. 2022;42(5):e0047521.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"3733_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrm3289","volume":"13","author":"JE Sale","year":"2012","unstructured":"Sale JE, Lehmann AR, Woodgate R. Y-family DNA polymerases and their role in tolerance of cellular DNA damage. Nat Rev Mol Cell Biol. 2012;13(3):141\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"3733_CR58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc3743","volume":"14","author":"A Losada","year":"2014","unstructured":"Losada A. Cohesin in cancer: chromosome segregation and beyond. Nat Rev Cancer. 2014;14(6):389\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"3733_CR59","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell. 2009;137(3):413\u201331.","journal-title":"Cell"},{"issue":"10","key":"3733_CR60","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9(10):749\u201358.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3733_CR61","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber ER, Lowe SW. Putting p53 in Context. Cell. 2017;170(6):1062\u201378.","journal-title":"Cell"},{"issue":"7530","key":"3733_CR62","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature13736","volume":"516","author":"H Basnet","year":"2014","unstructured":"Basnet H, Su XB, Tan Y, Meisenhelder J, Merkurjev D, Ohgi KA, et al. Tyrosine phosphorylation of histone H2A by CK2 regulates transcriptional elongation. Nature. 2014;516(7530):267\u201371.","journal-title":"Nature"},{"issue":"12","key":"3733_CR63","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008;8(12):957\u201367.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3733_CR64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrm.2016.48","volume":"17","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi R, Sarangi P, D\u2019Andrea AD. The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol. 2016;17(6):337\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"3733_CR65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrc.2017.116","volume":"18","author":"G Nalepa","year":"2018","unstructured":"Nalepa G, Clapp DW. Fanconi anaemia and cancer: an intricate relationship. Nat Rev Cancer. 2018;18(3):168\u201385.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3733_CR66","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.molcel.2006.06.024","volume":"23","author":"YJ Machida","year":"2006","unstructured":"Machida YJ, Machida Y, Chen Y, Gurtan AM, Kupfer GM, D\u2019Andrea AD, et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell. 2006;23(4):589\u201396.","journal-title":"Mol Cell"},{"issue":"6","key":"3733_CR67","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.molcel.2008.12.003","volume":"32","author":"AF Alpi","year":"2008","unstructured":"Alpi AF, Pace PE, Babu MM, Patel KJ. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell. 2008;32(6):767\u201377.","journal-title":"Mol Cell"},{"issue":"37","key":"3733_CR68","doi-asserted-by":"publisher","first-page":"32628","DOI":"10.1074\/jbc.M111.244632","volume":"286","author":"C Hodson","year":"2011","unstructured":"Hodson C, Cole AR, Lewis LP, Miles JA, Purkiss A, Walden H. Structural analysis of human FANCL, the E3 ligase in the Fanconi anemia pathway. J Biol Chem. 2011;286(37):32628\u201337.","journal-title":"J Biol Chem"},{"issue":"7655","key":"3733_CR69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature22366","volume":"545","author":"EL Huttlin","year":"2017","unstructured":"Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, et al. Architecture of the human interactome defines protein communities and disease networks. Nature. 2017;545(7655):505\u20139.","journal-title":"Nature"},{"issue":"11","key":"3733_CR70","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","volume":"184","author":"EL Huttlin","year":"2021","unstructured":"Huttlin EL, Bruckner RJ, Navarrete-Perea J, Cannon JR, Baltier K, Gebreab F, et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell. 2021;184(11):3022\u2013e4028.","journal-title":"Cell"},{"issue":"2","key":"3733_CR71","doi-asserted-by":"publisher","first-page":"e0229000","DOI":"10.1371\/journal.pone.0229000","volume":"15","author":"W Tan","year":"2020","unstructured":"Tan W, Murphy VJ, Charron A, van Twest S, Sharp M, Constantinou A, et al. Preparation and purification of mono-ubiquitinated proteins using Avi-tagged ubiquitin. PLoS ONE. 2020;15(2):e0229000.","journal-title":"PLoS ONE"},{"key":"3733_CR72","doi-asserted-by":"crossref","unstructured":"Zhang J, Wang J, Wu J, Huang J, Lin Z, Lin X. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT. Oncol Rep. 2022;48(2):139.","DOI":"10.3892\/or.2022.8350"},{"issue":"1","key":"3733_CR73","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1038\/s41467-019-10408-5","volume":"10","author":"F Liang","year":"2019","unstructured":"Liang F, Miller AS, Longerich S, Tang C, Maranon D, Williamson EA, et al. DNA requirement in FANCD2 deubiquitination by USP1-UAF1-RAD51AP1 in the Fanconi anemia DNA damage response. Nat Commun. 2019;10(1):2849.","journal-title":"Nat Commun"},{"issue":"7","key":"3733_CR74","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrc3088","volume":"11","author":"AJ Deans","year":"2011","unstructured":"Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer. 2011;11(7):467\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"3733_CR75","doi-asserted-by":"publisher","first-page":"23391","DOI":"10.1074\/jbc.M101855200","volume":"276","author":"F Qiao","year":"2001","unstructured":"Qiao F, Moss A, Kupfer GM. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J Biol Chem. 2001;276(26):23391\u20136.","journal-title":"J Biol Chem"},{"issue":"10","key":"3733_CR76","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1182\/blood-2007-09-113092","volume":"111","author":"JM Kim","year":"2008","unstructured":"Kim JM, Kee Y, Gurtan A, D\u2019Andrea AD. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM\/FAAP24. Blood. 2008;111(10):5215\u201322.","journal-title":"Blood"},{"issue":"8","key":"3733_CR77","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/sj.emboj.7601666","volume":"26","author":"C Ling","year":"2007","unstructured":"Ling C, Ishiai M, Ali AM, Medhurst AL, Neveling K, Kalb R, et al. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 2007;26(8):2104\u201314.","journal-title":"EMBO J"},{"issue":"12","key":"3733_CR78","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1073\/pnas.1118720109","volume":"109","author":"JW Leung","year":"2012","unstructured":"Leung JW, Wang Y, Fong KW, Huen MS, Li L, Chen J. Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair. Proc Natl Acad Sci USA. 2012;109(12):4491\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3733_CR79","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.celrep.2014.04.029","volume":"7","author":"Y Huang","year":"2014","unstructured":"Huang Y, Leung JW, Lowery M, Matsushita N, Wang Y, Shen X, et al. Modularized functions of the Fanconi anemia core complex. Cell Rep. 2014;7(6):1849\u201357.","journal-title":"Cell Rep"},{"issue":"5","key":"3733_CR80","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.molcel.2014.05.001","volume":"54","author":"E Rajendra","year":"2014","unstructured":"Rajendra E, Oestergaard VH, Langevin F, Wang M, Dornan GL, Patel KJ, et al. The genetic and biochemical basis of FANCD2 monoubiquitination. Mol Cell. 2014;54(5):858\u201369.","journal-title":"Mol Cell"},{"issue":"2","key":"3733_CR81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molcel.2016.11.005","volume":"65","author":"S van Twest","year":"2017","unstructured":"van Twest S, Murphy VJ, Hodson C, Tan W, Swuec P, O\u2019Rourke JJ, et al. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway. Mol Cell. 2017;65(2):247\u201359.","journal-title":"Mol Cell"},{"issue":"2","key":"3733_CR82","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1097-2765(01)00173-3","volume":"7","author":"I Garcia-Higuera","year":"2001","unstructured":"Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7(2):249\u201362.","journal-title":"Mol Cell"},{"issue":"2","key":"3733_CR83","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2007.03.009","volume":"129","author":"A Smogorzewska","year":"2007","unstructured":"Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER 3rd, Hurov KE, Luo J, et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell. 2007;129(2):289\u2013301.","journal-title":"Cell"},{"issue":"3","key":"3733_CR84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2008.10.009","volume":"32","author":"MA Cohn","year":"2008","unstructured":"Cohn MA, D\u2019Andrea AD. Chromatin recruitment of DNA repair proteins: lessons from the fanconi anemia and double-strand break repair pathways. Mol Cell. 2008;32(3):306\u201312.","journal-title":"Mol Cell"},{"issue":"9","key":"3733_CR85","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1093\/nar\/gku198","volume":"42","author":"S Longerich","year":"2014","unstructured":"Longerich S, Kwon Y, Tsai MS, Hlaing AS, Kupfer GM, Sung P. Regulation of FANCD2 and FANCI monoubiquitination by their interaction and by DNA. Nucleic Acids Res. 2014;42(9):5657\u201370.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"3733_CR86","doi-asserted-by":"publisher","first-page":"8752","DOI":"10.1158\/0008-5472.CAN-09-1809","volume":"69","author":"T Ueki","year":"2009","unstructured":"Ueki T, Park JH, Nishidate T, Kijima K, Hirata K, Nakamura Y, et al. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 2009;69(22):8752\u201360.","journal-title":"Cancer Res"},{"issue":"16","key":"3733_CR87","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/emboj.2009.193","volume":"28","author":"C Roques","year":"2009","unstructured":"Roques C, Coulombe Y, Delannoy M, Vignard J, Grossi S, Brodeur I, et al. MRE11-RAD50-NBS1 is a critical regulator of FANCD2 stability and function during DNA double-strand break repair. EMBO J. 2009;28(16):2400\u201313.","journal-title":"EMBO J"},{"issue":"1","key":"3733_CR88","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","volume":"26","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi R, Rondinelli B, D\u2019Andrea AD. Repair Pathway Choices and Consequences at the Double-Strand Break. Trends Cell Biol. 2016;26(1):52\u201364.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"3733_CR89","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccr.2012.05.015","volume":"22","author":"K Schlacher","year":"2012","unstructured":"Schlacher K, Wu H, Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1\/2. Cancer Cell. 2012;22(1):106\u201316.","journal-title":"Cancer Cell"},{"issue":"20","key":"3733_CR90","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMra0809889","volume":"362","author":"AD D\u2019Andrea","year":"2010","unstructured":"D\u2019Andrea AD. Susceptibility pathways in Fanconi\u2019s anemia and breast cancer. N Engl J Med. 2010;362(20):1909\u201319.","journal-title":"N Engl J Med"},{"issue":"13","key":"3733_CR91","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1101\/gad.195248.112","volume":"26","author":"H Kim","year":"2012","unstructured":"Kim H, D\u2019Andrea AD. Regulation of DNA cross-link repair by the Fanconi anemia\/BRCA pathway. Genes Dev. 2012;26(13):1393\u2013408.","journal-title":"Genes Dev"},{"issue":"10","key":"3733_CR92","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1158\/1541-7786.MCR-05-0192","volume":"3","author":"J Zhang","year":"2005","unstructured":"Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res. 2005;3(10):531\u20139.","journal-title":"Mol Cancer Res"},{"issue":"7169","key":"3733_CR93","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature06337","volume":"450","author":"AA Sartori","year":"2007","unstructured":"Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, et al. Human CtIP promotes DNA end resection. Nature. 2007;450(7169):509\u201314.","journal-title":"Nature"},{"issue":"10","key":"3733_CR94","doi-asserted-by":"publisher","first-page":"a012732","DOI":"10.1101\/cshperspect.a012732","volume":"5","author":"C Clauson","year":"2013","unstructured":"Clauson C, Scharer OD, Niedernhofer L. Advances in understanding the complex mechanisms of DNA interstrand cross-link repair. Cold Spring Harb Perspect Biol. 2013;5(10):a012732.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8027","key":"3733_CR95","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s41586-024-07770-w","volume":"632","author":"P Alcon","year":"2024","unstructured":"Alcon P, Kaczmarczyk AP, Ray KK, Liolios T, Guilbaud G, Sijacki T, et al. FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions. Nature. 2024;632(8027):1165\u201373.","journal-title":"Nature"},{"issue":"8053","key":"3733_CR96","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1038\/s41586-025-08763-z","volume":"639","author":"P Alcon","year":"2025","unstructured":"Alcon P, Kaczmarczyk AP, Ray KK, Liolios T, Guilbaud G, Sijacki T, et al. Author Correction: FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions. Nature. 2025;639(8053):E2.","journal-title":"Nature"},{"issue":"6","key":"3733_CR97","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","volume":"23","author":"Y Pommier","year":"2022","unstructured":"Pommier Y, Nussenzweig A, Takeda S, Austin C. Human topoisomerases and their roles in genome stability and organization. Nat Rev Mol Cell Biol. 2022;23(6):407\u201327.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3733_CR98","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbapap.2005.03.007","volume":"1749","author":"A Czubaty","year":"2005","unstructured":"Czubaty A, Girstun A, Kowalska-Loth B, Trzcinska AM, Purta E, Winczura A, et al. Proteomic analysis of complexes formed by human topoisomerase I. Biochim Biophys Acta. 2005;1749(1):133\u201341.","journal-title":"Biochim Biophys Acta"},{"issue":"6585","key":"3733_CR99","doi-asserted-by":"publisher","first-page":"eabi6983","DOI":"10.1126\/science.abi6983","volume":"375","author":"NH Cho","year":"2022","unstructured":"Cho NH, Cheveralls KC, Brunner AD, Kim K, Michaelis AC, Raghavan P, et al. OpenCell: Endogenous tagging for the cartography of human cellular organization. Science. 2022;375(6585):eabi6983.","journal-title":"Science"},{"issue":"1","key":"3733_CR100","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molcel.2021.11.016","volume":"82","author":"SK Das","year":"2022","unstructured":"Das SK, Kuzin V, Cameron DP, Sanford S, Jha RK, Nie Z, et al. MYC assembles and stimulates topoisomerases 1 and 2 in a topoisome. Mol Cell. 2022;82(1):140\u201358. e12.","journal-title":"Mol Cell"},{"issue":"5","key":"3733_CR101","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/nar\/gkg236","volume":"31","author":"VC Ogilvie","year":"2003","unstructured":"Ogilvie VC, Wilson BJ, Nicol SM, Morrice NA, Saunders LR, Barber GN, et al. The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells. Nucleic Acids Res. 2003;31(5):1470\u201380.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3733_CR102","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1093\/nar\/gkm058","volume":"35","author":"C Jalal","year":"2007","unstructured":"Jalal C, Uhlmann-Schiffler H, Stahl H. Redundant role of DEAD box proteins p68 (Ddx5) and p72\/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Res. 2007;35(11):3590\u2013601.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"3733_CR103","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.1158\/0008-5472.CAN-06-4652","volume":"67","author":"S Shin","year":"2007","unstructured":"Shin S, Rossow KL, Grande JP, Janknecht R. Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res. 2007;67(16):7572\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"3733_CR104","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.celrep.2014.05.010","volume":"7","author":"E Dardenne","year":"2014","unstructured":"Dardenne E, Polay Espinoza M, Fattet L, Germann S, Lambert MP, Neil H, et al. RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. Cell Rep. 2014;7(6):1900\u201313.","journal-title":"Cell Rep"},{"issue":"4","key":"3733_CR105","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/nar\/gkt1216","volume":"42","author":"S Samaan","year":"2014","unstructured":"Samaan S, Tranchevent LC, Dardenne E, Polay Espinoza M, Zonta E, Germann S, et al. The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways. Nucleic Acids Res. 2014;42(4):2197\u2013207.","journal-title":"Nucleic Acids Res"},{"key":"3733_CR106","doi-asserted-by":"crossref","unstructured":"Chapus F, Giraud G, Huchon P, Roda M, Grand X, Charre C et al. Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes. J Hepatol. 2024;81(4):609\u201320.","DOI":"10.1016\/j.jhep.2024.05.016"},{"issue":"4","key":"3733_CR107","doi-asserted-by":"publisher","first-page":"e1013009","DOI":"10.1371\/journal.ppat.1013009","volume":"21","author":"PK Sandhu","year":"2025","unstructured":"Sandhu PK, Damania B. RNA helicases, DDX5 and DDX17, facilitate lytic reactivation of gammaherpesviruses. PLoS Pathog. 2025;21(4):e1013009.","journal-title":"PLoS Pathog"},{"key":"3733_CR108","doi-asserted-by":"publisher","first-page":"943032","DOI":"10.3389\/fonc.2022.943032","volume":"12","author":"K Xu","year":"2022","unstructured":"Xu K, Sun S, Yan M, Cui J, Yang Y, Li W, et al. DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression. Front Oncol. 2022;12:943032.","journal-title":"Front Oncol"},{"issue":"4","key":"3733_CR109","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.molcel.2011.12.034","volume":"45","author":"A Hegele","year":"2012","unstructured":"Hegele A, Kamburov A, Grossmann A, Sourlis C, Wowro S, Weimann M, et al. Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell. 2012;45(4):567\u201380.","journal-title":"Mol Cell"},{"issue":"9","key":"3733_CR110","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nmeth.2131","volume":"9","author":"AR Kristensen","year":"2012","unstructured":"Kristensen AR, Gsponer J, Foster LJ. A high-throughput approach for measuring temporal changes in the interactome. Nat Methods. 2012;9(9):907\u20139.","journal-title":"Nat Methods"},{"issue":"11","key":"3733_CR111","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41590-022-01339-3","volume":"23","author":"X Ni","year":"2022","unstructured":"Ni X, Xu Y, Wang W, Kong B, Ouyang J, Chen J, et al. IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation. Nat Immunol. 2022;23(11):1577\u201387.","journal-title":"Nat Immunol"},{"issue":"3","key":"3733_CR112","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41388-022-02545-x","volume":"42","author":"C Jin","year":"2023","unstructured":"Jin C, Han-Hua D, Qiu-Meng L, Deng N, Peng-Chen D, Jie M, et al. MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma. Oncogene. 2023;42(3):169\u201383.","journal-title":"Oncogene"},{"issue":"13","key":"3733_CR113","first-page":"7218","volume":"48","author":"S Kim","year":"2020","unstructured":"Kim S, Kang N, Park SH, Wells J, Hwang T, Ryu E, et al. ATAD5 restricts R-loop formation through PCNA unloading and RNA helicase maintenance at the replication fork. Nucleic Acids Res. 2020;48(13):7218\u201338.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3733_CR114","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1038\/s41467-024-50428-4","volume":"15","author":"BZ Yang","year":"2024","unstructured":"Yang BZ, Liu MY, Chiu KL, Chien YL, Cheng CA, Chen YL, et al. DHX9 SUMOylation is required for the suppression of R-loop-associated genome instability. Nat Commun. 2024;15(1):6009.","journal-title":"Nat Commun"},{"issue":"1","key":"3733_CR115","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1038\/s41467-021-22337-3","volume":"12","author":"L Shi","year":"2021","unstructured":"Shi L, Magee P, Fassan M, Sahoo S, Leong HS, Lee D, et al. A KRAS-responsive long non-coding RNA controls microRNA processing. Nat Commun. 2021;12(1):2038.","journal-title":"Nat Commun"},{"issue":"7538","key":"3733_CR116","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature13923","volume":"518","author":"E Calo","year":"2015","unstructured":"Calo E, Flynn RA, Martin L, Spitale RC, Chang HY, Wysocka J. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing. Nature. 2015;518(7538):249\u201353.","journal-title":"Nature"},{"issue":"9","key":"3733_CR117","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.molcel.2024.03.006","volume":"84","author":"JD Hao","year":"2024","unstructured":"Hao JD, Liu QL, Liu MX, Yang X, Wang LM, Su SY, et al. DDX21 mediates co-transcriptional RNA m(6)A modification to promote transcription termination and genome stability. Mol Cell. 2024;84(9):1711\u2013e2611.","journal-title":"Mol Cell"},{"issue":"1","key":"3733_CR118","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12964-024-01869-3","volume":"22","author":"K Su","year":"2024","unstructured":"Su K, Zhao Z, Wang Y, Sun S, Liu X, Zhang C, et al. NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21. Cell Commun Signal. 2024;22(1):490.","journal-title":"Cell Commun Signal"},{"key":"3733_CR119","doi-asserted-by":"publisher","first-page":"122716","DOI":"10.1016\/j.lfs.2024.122716","volume":"349","author":"S Wang","year":"2024","unstructured":"Wang S, Yang R, Song M, Li J, Zhou Y, Dai C, et al. Current understanding of the role of DDX21 in orchestrating gene expression in health and diseases. Life Sci. 2024;349:122716.","journal-title":"Life Sci"},{"key":"3733_CR120","doi-asserted-by":"crossref","unstructured":"Xiao Y, Fan J, Li Z, Hou Y. DDX21 at the Nexus of RNA Metabolism, Cancer Oncogenesis, and Host-Virus Crosstalk: Decoding Its Biomarker Potential and Therapeutic Implications. Int J Mol Sci. 2024;25(24):13581.","DOI":"10.3390\/ijms252413581"},{"issue":"1","key":"3733_CR121","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1038\/s41467-018-06677-1","volume":"9","author":"P Chakraborty","year":"2018","unstructured":"Chakraborty P, Huang JTJ, Hiom K. DHX9 helicase promotes R-loop formation in cells with impaired RNA splicing. Nat Commun. 2018;9(1):4346.","journal-title":"Nat Commun"},{"issue":"1","key":"3733_CR122","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1038\/s41467-021-24341-z","volume":"12","author":"P Chakraborty","year":"2021","unstructured":"Chakraborty P, Hiom K. DHX9-dependent recruitment of BRCA1 to RNA promotes DNA end resection in homologous recombination. Nat Commun. 2021;12(1):4126.","journal-title":"Nat Commun"},{"issue":"5","key":"3733_CR123","doi-asserted-by":"publisher","first-page":"eadd5005","DOI":"10.1126\/sciadv.add5005","volume":"9","author":"X Ren","year":"2023","unstructured":"Ren X, Wang D, Zhang G, Zhou T, Wei Z, Yang Y, et al. Nucleic DHX9 cooperates with STAT1 to transcribe interferon-stimulated genes. Sci Adv. 2023;9(5):eadd5005.","journal-title":"Sci Adv"},{"issue":"1","key":"3733_CR124","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1038\/s41467-024-47235-2","volume":"15","author":"X Ren","year":"2024","unstructured":"Ren X, Liu Q, Zhou P, Zhou T, Wang D, Mei Q, et al. DHX9 maintains epithelial homeostasis by restraining R-loop-mediated genomic instability in intestinal stem cells. Nat Commun. 2024;15(1):3080.","journal-title":"Nat Commun"},{"issue":"7865","key":"3733_CR125","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-021-03592-2","volume":"595","author":"CD Go","year":"2021","unstructured":"Go CD, Knight JDR, Rajasekharan A, Rathod B, Hesketh GG, Abe KT, et al. A proximity-dependent biotinylation map of a human cell. Nature. 2021;595(7865):120\u20134.","journal-title":"Nature"},{"issue":"Pt 9","key":"3733_CR126","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awv167","volume":"138","author":"J Yin","year":"2015","unstructured":"Yin J, Park G, Lee JE, Choi EY, Park JY, Kim TH, et al. DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis. Brain. 2015;138(Pt 9):2553\u201370.","journal-title":"Brain"},{"issue":"24","key":"3733_CR127","doi-asserted-by":"publisher","first-page":"38937","DOI":"10.18632\/oncotarget.17156","volume":"8","author":"G Mao","year":"2017","unstructured":"Mao G, Jin H, Wu L. DDX23-Linc00630-HDAC1 axis activates the Notch pathway to promote metastasis. Oncotarget. 2017;8(24):38937\u201349.","journal-title":"Oncotarget"},{"issue":"2","key":"3733_CR128","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.celrep.2016.12.050","volume":"18","author":"SC Sridhara","year":"2017","unstructured":"Sridhara SC, Carvalho S, Grosso AR, Gallego-Paez LM, Carmo-Fonseca M, de Almeida SF. Transcription Dynamics Prevent RNA-Mediated Genomic Instability through SRPK2-Dependent DDX23 Phosphorylation. Cell Rep. 2017;18(2):334\u201343.","journal-title":"Cell Rep"},{"issue":"1","key":"3733_CR129","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbcan.2018.11.003","volume":"1871","author":"RM Nyamao","year":"2019","unstructured":"Nyamao RM, Wu J, Yu L, Xiao X, Zhang FM. Roles of DDX5 in the tumorigenesis, proliferation, differentiation, metastasis and pathway regulation of human malignancies. Biochim Biophys Acta Rev Cancer. 2019;1871(1):85\u201398.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"10","key":"3733_CR130","first-page":"5190","volume":"11","author":"F Li","year":"2021","unstructured":"Li F, Fountzilas C, Puzanov I, Attwood KM, Morrison C, Ling X. Multiple functions of the DEAD-box RNA helicase, DDX5 (p68), make DDX5 a superior oncogenic biomarker and target for targeted cancer therapy. Am J Cancer Res. 2021;11(10):5190\u2013213.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"3733_CR131","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10549-018-4957-x","volume":"172","author":"C Du","year":"2018","unstructured":"Du C, Mark D, Wappenschmidt B, Bockmann B, Pabst B, Chan S, et al. A tandem duplication of BRCA1 exons 1\u201319 through DHX8 exon 2 in four families with hereditary breast and ovarian cancer syndrome. Breast Cancer Res Treat. 2018;172(3):561\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"3733_CR132","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejca.2022.04.012","volume":"169","author":"C Wang","year":"2022","unstructured":"Wang C, Hu Q, Sun Y, Yu F, Peng M. Complete pathological remission after neoadjuvant ensartinib in patients with locally advanced lung adenocarcinoma and with CTLC-ALK and ALK-DHX8 rearrangements. Eur J Cancer. 2022;169:131\u20134.","journal-title":"Eur J Cancer"},{"issue":"7","key":"3733_CR133","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1093\/nar\/gkaa1296","volume":"49","author":"T Suzuki","year":"2021","unstructured":"Suzuki T, Katada E, Mizuoka Y, Takagi S, Kazuki Y, Oshimura M, et al. A novel all-in-one conditional knockout system uncovered an essential role of DDX1 in ribosomal RNA processing. Nucleic Acids Res. 2021;49(7):e40.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3733_CR134","doi-asserted-by":"publisher","first-page":"102180","DOI":"10.1016\/j.jbc.2022.102180","volume":"298","author":"L Li","year":"2022","unstructured":"Li L, Garg M, Wang Y, Wang W, Godbout R. DEAD box 1 (DDX1) protein binds to and protects cytoplasmic stress response mRNAs in cells exposed to oxidative stress. J Biol Chem. 2022;298(8):102180.","journal-title":"J Biol Chem"},{"issue":"4","key":"3733_CR135","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cncr.26352","volume":"118","author":"NK Taunk","year":"2012","unstructured":"Taunk NK, Goyal S, Wu H, Moran MS, Chen S, Haffty BG. DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer. Cancer. 2012;118(4):888\u201398.","journal-title":"Cancer"},{"issue":"1","key":"3733_CR136","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s43657-021-00034-x","volume":"2","author":"B Gao","year":"2022","unstructured":"Gao B, Li X, Li S, Wang S, Wu J, Li J. Pan-cancer analysis identifies RNA helicase DDX1 as a prognostic marker. Phenomics. 2022;2(1):33\u201349.","journal-title":"Phenomics"},{"key":"3733_CR137","doi-asserted-by":"publisher","first-page":"121592","DOI":"10.1016\/j.lfs.2023.121592","volume":"323","author":"Q Yang","year":"2023","unstructured":"Yang Q, Xu P, Liu Q, Hu F, Xie X, Jiang L, et al. Depleting DDX1 sensitizes non-small cell lung cancer cells to chemotherapy by attenuating cancer stem cell traits. Life Sci. 2023;323:121592.","journal-title":"Life Sci"},{"issue":"4","key":"3733_CR138","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.molcel.2018.04.001","volume":"70","author":"C Ribeiro de Almeida","year":"2018","unstructured":"Ribeiro de Almeida C, Dhir S, Dhir A, Moghaddam AE, Sattentau Q, Meinhart A, et al. RNA Helicase DDX1 Converts RNA G-Quadruplex Structures into R-Loops to Promote IgH Class Switch Recombination. Mol Cell. 2018;70(4):650\u201362. e8.","journal-title":"Mol Cell"},{"issue":"12","key":"3733_CR139","doi-asserted-by":"publisher","first-page":"e13325","DOI":"10.1111\/cpr.13325","volume":"55","author":"L Chen","year":"2022","unstructured":"Chen L, Liu Z, Tang H, Zhou Z, Chen J, Ma Z, et al. Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer. Cell Prolif. 2022;55(12):e13325.","journal-title":"Cell Prolif"},{"issue":"2","key":"3733_CR140","doi-asserted-by":"publisher","first-page":"105646","DOI":"10.1016\/j.jbc.2024.105646","volume":"300","author":"JL de Amorim","year":"2024","unstructured":"de Amorim JL, Leung SW, Haji-Seyed-Javadi R, Hou Y, Yu DS, Ghalei H, et al. The putative RNA helicase DDX1 associates with the nuclear RNA exosome and modulates RNA\/DNA hybrids (R-loops). J Biol Chem. 2024;300(2):105646.","journal-title":"J Biol Chem"},{"key":"3733_CR141","doi-asserted-by":"crossref","unstructured":"Ferri D, Branca G, Lanzafame M, Gandolfi E, Riva V, Maga G et al. Trichothiodystrophy-causative pathogenic variants impair a cooperative action of TFIIH and DDX1 in R-loop processing. Nucleic Acids Res. 2025;53(14):gkaf745.","DOI":"10.1093\/nar\/gkaf745"},{"issue":"5","key":"3733_CR142","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.celrep.2014.07.058","volume":"8","author":"C Han","year":"2014","unstructured":"Han C, Liu Y, Wan G, Choi HJ, Zhao L, Ivan C, et al. The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression. Cell Rep. 2014;8(5):1447\u201360.","journal-title":"Cell Rep"},{"issue":"8","key":"3733_CR143","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/cas.13661","volume":"109","author":"K Tanaka","year":"2018","unstructured":"Tanaka K, Ikeda N, Miyashita K, Nuriya H, Hara T. DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene. Cancer Sci. 2018;109(8):2479\u201389.","journal-title":"Cancer Sci"},{"issue":"9","key":"3733_CR144","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1093\/nar\/gkg328","volume":"31","author":"K Zhou","year":"2003","unstructured":"Zhou K, Choe KT, Zaidi Z, Wang Q, Mathews MB, Lee CG. RNA helicase A interacts with dsDNA and topoisomerase IIalpha. Nucleic Acids Res. 2003;31(9):2253\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3733_CR145","doi-asserted-by":"publisher","first-page":"10803","DOI":"10.1038\/s41467-024-55054-8","volume":"15","author":"X Shi","year":"2024","unstructured":"Shi X, Li Y, Zhou H, Hou X, Yang J, Malik V, et al. DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells. Nat Commun. 2024;15(1):10803.","journal-title":"Nat Commun"},{"issue":"4","key":"3733_CR146","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1182\/blood-2010-11-318022","volume":"118","author":"EM Payne","year":"2011","unstructured":"Payne EM, Bolli N, Rhodes J, Abdel-Wahab OI, Levine R, Hedvat CV, et al. Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood. 2011;118(4):903\u201315.","journal-title":"Blood"},{"issue":"29","key":"3733_CR147","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1038\/onc.2014.323","volume":"34","author":"AM Redmond","year":"2015","unstructured":"Redmond AM, Byrne C, Bane FT, Brown GD, Tibbitts P, O\u2019Brien K, et al. Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells. Oncogene. 2015;34(29):3871\u201380.","journal-title":"Oncogene"},{"key":"3733_CR148","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.virusres.2017.05.028","volume":"238","author":"H Jin","year":"2017","unstructured":"Jin H, Zhou L, Ge X, Zhang H, Zhang R, Wang C, et al. Cellular DEAD-box RNA helicase 18 (DDX18) Promotes the PRRSV Replication via Interaction with Virus nsp2 and nsp10. Virus Res. 2017;238:204\u201312.","journal-title":"Virus Res"},{"issue":"3","key":"3733_CR149","doi-asserted-by":"publisher","first-page":"111089","DOI":"10.1016\/j.celrep.2022.111089","volume":"40","author":"WL Lin","year":"2022","unstructured":"Lin WL, Chen JK, Wen X, He W, Zarceno GA, Chen Y, et al. DDX18 prevents R-loop-induced DNA damage and genome instability via PARP-1. Cell Rep. 2022;40(3):111089.","journal-title":"Cell Rep"},{"issue":"40","key":"3733_CR150","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1038\/s41388-023-02817-0","volume":"42","author":"G Dong","year":"2023","unstructured":"Dong G, Wang Q, Wen M, Xia Z, Zhang S, Gao W, et al. DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer. Oncogene. 2023;42(40):3000\u201314.","journal-title":"Oncogene"},{"issue":"1","key":"3733_CR151","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s12967-025-06555-7","volume":"23","author":"X Ma","year":"2025","unstructured":"Ma X, He Y, Yang Y, Lu T, Tang Z, Cui Y, et al. YY1-induced DDX18 modulates EMT via the AKT\/mTOR pathway in esophageal cancer: a novel therapeutic target. J Transl Med. 2025;23(1):562.","journal-title":"J Transl Med"},{"key":"3733_CR152","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1038\/ncomms7572","volume":"6","author":"R Broderick","year":"2015","unstructured":"Broderick R, Nieminuszczy J, Blackford AN, Winczura A, Niedzwiedz W. TOPBP1 recruits TOP2A to ultra-fine anaphase bridges to aid in their resolution. Nat Commun. 2015;6:6572.","journal-title":"Nat Commun"},{"issue":"4","key":"3733_CR153","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41556-020-0493-0","volume":"22","author":"C Santoriello","year":"2020","unstructured":"Santoriello C, Sporrij A, Yang S, Flynn RA, Henriques T, Dorjsuren B, et al. RNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cells. Nat Cell Biol. 2020;22(4):372\u20139.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3733_CR154","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1038\/s41467-018-07101-4","volume":"9","author":"SK Lee","year":"2018","unstructured":"Lee SK, Xue Y, Shen W, Zhang Y, Joo Y, Ahmad M, et al. Topoisomerase 3beta interacts with RNAi machinery to promote heterochromatin formation and transcriptional silencing in Drosophila. Nat Commun. 2018;9(1):4946.","journal-title":"Nat Commun"},{"issue":"2","key":"3733_CR155","doi-asserted-by":"publisher","first-page":"111067","DOI":"10.1016\/j.celrep.2022.111067","volume":"40","author":"S Saha","year":"2022","unstructured":"Saha S, Yang X, Huang SN, Agama K, Baechler SA, Sun Y, et al. Resolution of R-loops by topoisomerase III-beta (TOP3B) in coordination with the DEAD-box helicase DDX5. Cell Rep. 2022;40(2):111067.","journal-title":"Cell Rep"},{"issue":"6","key":"3733_CR156","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.molcel.2010.11.024","volume":"40","author":"Y Yang","year":"2010","unstructured":"Yang Y, Lu Y, Espejo A, Wu J, Xu W, Liang S, et al. TDRD3 is an effector molecule for arginine-methylated histone marks. Mol Cell. 2010;40(6):1016\u201323.","journal-title":"Mol Cell"},{"issue":"3","key":"3733_CR157","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2014.01.011","volume":"53","author":"Y Yang","year":"2014","unstructured":"Yang Y, McBride KM, Hensley S, Lu Y, Chedin F, Bedford MT. Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation. Mol Cell. 2014;53(3):484\u201397.","journal-title":"Mol Cell"},{"key":"3733_CR158","doi-asserted-by":"publisher","first-page":"16048","DOI":"10.1038\/celldisc.2016.48","volume":"3","author":"N Narayanan","year":"2017","unstructured":"Narayanan N, Wang Z, Li L, Yang Y. Arginine methylation of USP9X promotes its interaction with TDRD3 and its anti-apoptotic activities in breast cancer cells. Cell Discov. 2017;3:16048.","journal-title":"Cell Discov"},{"issue":"9","key":"3733_CR159","doi-asserted-by":"publisher","first-page":"e45571","DOI":"10.1371\/journal.pone.0045571","volume":"7","author":"X Ling","year":"2012","unstructured":"Ling X, Cao S, Cheng Q, Keefe JT, Rustum YM, Li FA, Novel Small. Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity. PLoS ONE. 2012;7(9):e45571.","journal-title":"PLoS ONE"},{"issue":"2","key":"3733_CR160","first-page":"370","volume":"7","author":"F Li","year":"2017","unstructured":"Li F, Ling X, Harris DL, Liao J, Wang Y, Westover D, et al. Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity? Am J Cancer Res. 2017;7(2):370\u201382.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3733_CR161","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev-biochem-091724-010717","volume":"94","author":"L Baranello","year":"2025","unstructured":"Baranello L, Kouzine F, Levens D. Topoisomerase Regulation of Cancer Gene Expression. Annu Rev Biochem. 2025;94(1):333\u201359.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"3733_CR162","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13(1):104.","journal-title":"J Hematol Oncol"},{"issue":"14","key":"3733_CR163","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1158\/0008-5472.CAN-11-2876","volume":"72","author":"M He","year":"2012","unstructured":"He M, Zhang W, Bakken T, Schutten M, Toth Z, Jung JU, et al. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. Cancer Res. 2012;72(14):3582\u201392.","journal-title":"Cancer Res"},{"issue":"24","key":"3733_CR164","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41388-023-02709-3","volume":"42","author":"R El Baba","year":"2023","unstructured":"El Baba R, Pasquereau S, Haidar Ahmad S, Monnien F, Abad M, Bibeau F, et al. EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes. Oncogene. 2023;42(24):2031\u201345.","journal-title":"Oncogene"},{"key":"3733_CR165","doi-asserted-by":"crossref","unstructured":"El Baba R, Herbein G. EZH2-Myc Hallmark in Oncovirus\/Cytomegalovirus Infections and Cytomegalovirus\u2019 Resemblance to Oncoviruses. Cells. 2024;13(6):541.","DOI":"10.3390\/cells13060541"},{"issue":"39","key":"3733_CR166","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1038\/s41388-021-01982-4","volume":"40","author":"SH Park","year":"2021","unstructured":"Park SH, Fong KW, Mong E, Martin MC, Schiltz GE, Yu J. Going beyond Polycomb: EZH2 functions in prostate cancer. Oncogene. 2021;40(39):5788\u201398.","journal-title":"Oncogene"},{"issue":"1","key":"3733_CR167","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","volume":"15","author":"VB Venkadakrishnan","year":"2024","unstructured":"Venkadakrishnan VB, Presser AG, Singh R, Booker MA, Traphagen NA, Weng K, et al. Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Nat Commun. 2024;15(1):6779.","journal-title":"Nat Commun"},{"issue":"3","key":"3733_CR168","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22(3):298\u2013305.","journal-title":"Nat Med"},{"issue":"8","key":"3733_CR169","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","volume":"52","author":"SG Zhao","year":"2020","unstructured":"Zhao SG, Chen WS, Li H, Foye A, Zhang M, Sjostrom M, et al. The DNA methylation landscape of advanced prostate cancer. Nat Genet. 2020;52(8):778\u201389.","journal-title":"Nat Genet"},{"issue":"1","key":"3733_CR170","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1038\/s41467-021-26042-z","volume":"12","author":"P Cejas","year":"2021","unstructured":"Cejas P, Xie Y, Font-Tello A, Lim K, Syamala S, Qiu X, et al. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer. Nat Commun. 2021;12(1):5775.","journal-title":"Nat Commun"},{"issue":"6596","key":"3733_CR171","doi-asserted-by":"publisher","first-page":"eabe1505","DOI":"10.1126\/science.abe1505","volume":"376","author":"F Tang","year":"2022","unstructured":"Tang F, Xu D, Wang S, Wong CK, Martinez-Fundichely A, Lee CJ, et al. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science. 2022;376(6596):eabe1505.","journal-title":"Science"},{"issue":"6","key":"3733_CR172","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1470-2045(22)00277-7","volume":"23","author":"MG Zauderer","year":"2022","unstructured":"Zauderer MG, Szlosarek PW, Le Moulec S, Popat S, Taylor P, Planchard D, et al. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2022;23(6):758\u201367.","journal-title":"Lancet Oncol"},{"key":"3733_CR173","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1038\/ncomms4127","volume":"5","author":"Q Cao","year":"2014","unstructured":"Cao Q, Wang X, Zhao M, Yang R, Malik R, Qiao Y, et al. The central role of EED in the orchestration of polycomb group complexes. Nat Commun. 2014;5:3127.","journal-title":"Nat Commun"},{"issue":"2","key":"3733_CR174","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41419-021-03491-4","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Sun Y, Shang C, Chen L, Chen H, Wang D, et al. Distinct Ring1b complexes defined by DEAD-box helicases and EMT transcription factors synergistically enhance E-cadherin silencing in breast cancer. Cell Death Dis. 2021;12(2):202.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3733_CR175","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41388-022-02570-w","volume":"42","author":"T Yu","year":"2023","unstructured":"Yu T, Zhou F, Tian W, Xu R, Wang B, Zeng A, et al. EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene. 2023;42(6):461\u201370.","journal-title":"Oncogene"},{"issue":"1","key":"3733_CR176","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1038\/s41467-025-59003-x","volume":"16","author":"A Sakhuja","year":"2025","unstructured":"Sakhuja A, Bhattacharyya R, Katakia YT, Ramakrishnan SK, Chakraborty S, Jayakumar H, et al. S-nitrosylation of EZH2 alters PRC2 assembly, methyltransferase activity, and EZH2 stability to maintain endothelial homeostasis. Nat Commun. 2025;16(1):3953.","journal-title":"Nat Commun"},{"issue":"1","key":"3733_CR177","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ccell.2018.11.014","volume":"35","author":"S Erkek","year":"2019","unstructured":"Erkek S, Johann PD, Finetti MA, Drosos Y, Chou HC, Zapatka M, et al. Comprehensive Analysis of Chromatin States in Atypical Teratoid\/Rhabdoid Tumor Identifies Diverging Roles for SWI\/SNF and Polycomb in Gene Regulation. Cancer Cell. 2019;35(1):95\u2013110. e8.","journal-title":"Cancer Cell"},{"issue":"4","key":"3733_CR178","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.stem.2016.12.002","volume":"20","author":"H Li","year":"2017","unstructured":"Li H, Lai P, Jia J, Song Y, Xia Q, Huang K, et al. RNA Helicase DDX5 Inhibits Reprogramming to Pluripotency by miRNA-Based Repression of RYBP and its PRC1-Dependent and -Independent Functions. Cell Stem Cell. 2017;20(4):462\u201377. e6.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3733_CR179","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.celrep.2019.12.021","volume":"30","author":"H Zhang","year":"2020","unstructured":"Zhang H, Wu Z, Lu JY, Huang B, Zhou H, Xie W, et al. DEAD-Box Helicase 18 Counteracts PRC2 to Safeguard Ribosomal DNA in Pluripotency Regulation. Cell Rep. 2020;30(1):81\u201397. e7.","journal-title":"Cell Rep"},{"issue":"5","key":"3733_CR180","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.molcel.2018.01.039","volume":"69","author":"S Chen","year":"2018","unstructured":"Chen S, Jiao L, Shubbar M, Yang X, Liu X. Unique Structural Platforms of Suz12 Dictate Distinct Classes of PRC2 for Chromatin Binding. Mol Cell. 2018;69(5):840\u201352. e5.","journal-title":"Mol Cell"},{"issue":"6378","key":"3733_CR181","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1126\/science.aar5700","volume":"359","author":"V Kasinath","year":"2018","unstructured":"Kasinath V, Faini M, Poepsel S, Reif D, Feng XA, Stjepanovic G, et al. Structures of human PRC2 with its cofactors AEBP2 and JARID2. Science. 2018;359(6378):940\u20134.","journal-title":"Science"},{"key":"3733_CR182","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2018.08.021","volume":"437","author":"H Zhang","year":"2018","unstructured":"Zhang H, Zhang Y, Chen C, Zhu X, Zhang C, Xia Y, et al. A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer. Cancer Lett. 2018;437:67\u201378.","journal-title":"Cancer Lett"},{"issue":"39","key":"3733_CR183","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1038\/onc.2010.276","volume":"29","author":"CL Carter","year":"2010","unstructured":"Carter CL, Lin C, Liu CY, Yang L, Liu ZR. Phosphorylated p68 RNA helicase activates Snail1 transcription by promoting HDAC1 dissociation from the Snail1 promoter. Oncogene. 2010;29(39):5427\u201336.","journal-title":"Oncogene"},{"issue":"3","key":"3733_CR184","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/jcb.23428","volume":"113","author":"YJ Choi","year":"2012","unstructured":"Choi YJ, Lee SG. The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2\/M phase of the cycle, and affects its shuttling during mRNP export. J Cell Biochem. 2012;113(3):985\u201396.","journal-title":"J Cell Biochem"},{"issue":"19","key":"3733_CR185","doi-asserted-by":"publisher","first-page":"11973","DOI":"10.1093\/nar\/gkae712","volume":"52","author":"H Choi","year":"2024","unstructured":"Choi H, Zhou L, Zhao Y, Dean J. RNA helicase D1PAS1 resolves R-loops and forms a complex for mouse pachytene piRNA biogenesis required for male fertility. Nucleic Acids Res. 2024;52(19):11973\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"3733_CR186","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/s44319-025-00425-5","volume":"26","author":"E Senatore","year":"2025","unstructured":"Senatore E, Avolio R, Rinaldi L, Chiuso F, Oliva MA, D\u2019Ambrosio C, et al. Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6. EMBO Rep. 2025;26(9):2347\u201377.","journal-title":"EMBO Rep"},{"issue":"7","key":"3733_CR187","doi-asserted-by":"publisher","first-page":"e23581","DOI":"10.1096\/fj.202400166R","volume":"38","author":"X Deng","year":"2024","unstructured":"Deng X, Liu Z, Wang B, Ma J, Meng X. The DDX6\/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer. FASEB J. 2024;38(7):e23581.","journal-title":"FASEB J"},{"issue":"36","key":"3733_CR188","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41388-024-03119-9","volume":"43","author":"J Corbin","year":"2024","unstructured":"Corbin J, Yu X, Jin J, Cai L, Wang GG. EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth. Oncogene. 2024;43(36):2722\u201336.","journal-title":"Oncogene"},{"issue":"12","key":"3733_CR189","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1158\/0008-5472.CAN-19-2415","volume":"80","author":"S Hoxha","year":"2020","unstructured":"Hoxha S, Shepard A, Troutman S, Diao H, Doherty JR, Janiszewska M, et al. YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators. Cancer Res. 2020;80(12):2512\u201322.","journal-title":"Cancer Res"},{"key":"3733_CR190","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/celldisc.2016.41","volume":"2","author":"CR Jeter","year":"2016","unstructured":"Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, et al. NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR\/FOXA1 signaling axis. Cell Discov. 2016;2:16041.","journal-title":"Cell Discov"},{"issue":"36","key":"3733_CR191","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1038\/onc.2011.114","volume":"30","author":"CR Jeter","year":"2011","unstructured":"Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011;30(36):3833\u201345.","journal-title":"Oncogene"},{"key":"3733_CR192","doi-asserted-by":"publisher","first-page":"1410102","DOI":"10.3389\/fcell.2024.1410102","volume":"12","author":"H Su","year":"2024","unstructured":"Su H, Huang L, Zhou J, Yang G. Prostate cancer stem cells and their targeted therapies. Front Cell Dev Biol. 2024;12:1410102.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3733_CR193","doi-asserted-by":"publisher","first-page":"2393442","DOI":"10.1080\/2162402X.2024.2393442","volume":"13","author":"K Kainulainen","year":"2024","unstructured":"Kainulainen K, Niskanen EA, Kinnunen J, Maki-Mantila K, Hartikainen K, Paakinaho V, et al. Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NFkappaB-signaling. Oncoimmunology. 2024;13(1):2393442.","journal-title":"Oncoimmunology"},{"key":"3733_CR194","doi-asserted-by":"crossref","unstructured":"Burramsetty AK, Nishimura K, Kishimoto T, Hamzah M, Kuno A, Fukuda A et al. Locus-Specific Isolation of the Nanog Chromatin Identifies Regulators Relevant to Pluripotency of Mouse Embryonic Stem Cells and Reprogramming of Somatic Cells. Int J Mol Sci. 2022;23(23):15242.","DOI":"10.3390\/ijms232315242"},{"issue":"39","key":"3733_CR195","doi-asserted-by":"publisher","first-page":"26533","DOI":"10.1074\/jbc.M109.027466","volume":"284","author":"LY Bourguignon","year":"2009","unstructured":"Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem. 2009;284(39):26533\u201346.","journal-title":"J Biol Chem"},{"issue":"16","key":"3733_CR196","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/emboj.2013.161","volume":"32","author":"A Gagliardi","year":"2013","unstructured":"Gagliardi A, Mullin NP, Ying Tan Z, Colby D, Kousa AI, Halbritter F, et al. A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. EMBO J. 2013;32(16):2231\u201347.","journal-title":"EMBO J"},{"issue":"9","key":"3733_CR197","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.stem.2021.04.001","volume":"28","author":"J Bayerl","year":"2021","unstructured":"Bayerl J, Ayyash M, Shani T, Manor YS, Gafni O, Massarwa R, et al. Principles of signaling pathway modulation for enhancing human naive pluripotency induction. Cell Stem Cell. 2021;28(9):1549\u2013e6512.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3733_CR198","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2020.07.053","volume":"159","author":"S Karmakar","year":"2020","unstructured":"Karmakar S, Rauth S, Nallasamy P, Perumal N, Nimmakayala RK, Leon F, et al. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3. Gastroenterology. 2020;159(5):1898\u2013915. e6.","journal-title":"Gastroenterology"},{"key":"3733_CR199","doi-asserted-by":"publisher","first-page":"18388","DOI":"10.1038\/srep18388","volume":"5","author":"G Oliviero","year":"2015","unstructured":"Oliviero G, Munawar N, Watson A, Streubel G, Manning G, Bardwell V, et al. The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis. Sci Rep. 2015;5:18388.","journal-title":"Sci Rep"},{"issue":"6","key":"3733_CR200","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2008.04.043","volume":"133","author":"X Chen","year":"2008","unstructured":"Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 2008;133(6):1106\u201317.","journal-title":"Cell"},{"issue":"6","key":"3733_CR201","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41588-019-0408-9","volume":"51","author":"QV Li","year":"2019","unstructured":"Li QV, Dixon G, Verma N, Rosen BP, Gordillo M, Luo R, et al. Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation. Nat Genet. 2019;51(6):999\u20131010.","journal-title":"Nat Genet"},{"issue":"3","key":"3733_CR202","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2018.11.035","volume":"48","author":"J Zhang","year":"2019","unstructured":"Zhang J, Chen M, Zhu Y, Dai X, Dang F, Ren J, et al. SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression. Dev Cell. 2019;48(3):329\u201344. e5.","journal-title":"Dev Cell"},{"issue":"7","key":"3733_CR203","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2018.10.042","volume":"175","author":"A Boija","year":"2018","unstructured":"Boija A, Klein IA, Sabari BR, Dall\u2019Agnese A, Coffey EL, Zamudio AV, et al. Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains. Cell. 2018;175(7):1842\u2013e5516.","journal-title":"Cell"},{"issue":"5","key":"3733_CR204","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.stem.2009.03.009","volume":"4","author":"L Ding","year":"2009","unstructured":"Ding L, Paszkowski-Rogacz M, Nitzsche A, Slabicki MM, Heninger AK, de Vries I, et al. A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell. 2009;4(5):403\u201315.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3733_CR205","first-page":"442","volume":"168","author":"C Chronis","year":"2017","unstructured":"Chronis C, Fiziev P, Papp B, Butz S, Bonora G, Sabri S, et al. Coop Binding Transcription Factors Orchestrates Reprogramming Cell. 2017;168(3):442\u201359. e20.","journal-title":"Coop Binding Transcription Factors Orchestrates Reprogramming Cell"},{"issue":"5","key":"3733_CR206","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41556-022-00896-x","volume":"24","author":"KJ Choi","year":"2022","unstructured":"Choi KJ, Quan MD, Qi C, Lee JH, Tsoi PS, Zahabiyon M, et al. NANOG prion-like assembly mediates DNA bridging to facilitate chromatin reorganization and activation of pluripotency. Nat Cell Biol. 2022;24(5):737\u201347.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"3733_CR207","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/cr.2016.15","volume":"26","author":"C Zhou","year":"2016","unstructured":"Zhou C, Yang X, Sun Y, Yu H, Zhang Y, Jin Y. Comprehensive profiling reveals mechanisms of SOX2-mediated cell fate specification in human ESCs and NPCs. Cell Res. 2016;26(2):171\u201389.","journal-title":"Cell Res"},{"issue":"1","key":"3733_CR208","doi-asserted-by":"publisher","first-page":"109695","DOI":"10.1016\/j.celrep.2021.109695","volume":"37","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang Y, Zhang S, Kim B, Hull VL, Xu J, et al. PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination. Cell Rep. 2021;37(1):109695.","journal-title":"Cell Rep"},{"issue":"6","key":"3733_CR209","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.cell.2008.02.039","volume":"132","author":"J Kim","year":"2008","unstructured":"Kim J, Chu J, Shen X, Wang J, Orkin SH. An extended transcriptional network for pluripotency of embryonic stem cells. Cell. 2008;132(6):1049\u201361.","journal-title":"Cell"},{"issue":"21","key":"3733_CR210","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1101\/gad.1837309","volume":"23","author":"S Bilodeau","year":"2009","unstructured":"Bilodeau S, Kagey MH, Frampton GM, Rahl PB, Young RA. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev. 2009;23(21):2484\u20139.","journal-title":"Genes Dev"},{"key":"3733_CR211","doi-asserted-by":"publisher","first-page":"100064","DOI":"10.1016\/j.mcpro.2021.100064","volume":"20","author":"L Velot","year":"2021","unstructured":"Velot L, Lessard F, Berube-Simard FA, Tav C, Neveu B, Teyssier V, et al. Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner. Mol Cell Proteom. 2021;20:100064.","journal-title":"Mol Cell Proteom"},{"issue":"5","key":"3733_CR212","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41419-020-2506-0","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Cao L, Dong X, Wu F, De W, Huang L, et al. LINC01116 promotes tumor proliferation and neutrophil recruitment via DDX5-mediated regulation of IL-1beta in glioma cell. Cell Death Dis. 2020;11(5):302.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3733_CR213","doi-asserted-by":"publisher","first-page":"103055","DOI":"10.1016\/j.isci.2021.103055","volume":"24","author":"CR Dixon","year":"2021","unstructured":"Dixon CR, Malik P, de Las Heras JI, Saiz-Ros N, de Lima Alves F, Tingey M, et al. STING nuclear partners contribute to innate immune signaling responses. iScience. 2021;24(9):103055.","journal-title":"iScience"},{"issue":"5","key":"3733_CR214","doi-asserted-by":"publisher","first-page":"eadd6165","DOI":"10.1126\/sciadv.add6165","volume":"9","author":"S Ma","year":"2023","unstructured":"Ma S, Yang Q, Chen N, Zheng A, Abbasi N, Wang G, et al. RNA binding protein DDX5 restricts RORgammat(+) T(reg) suppressor function to promote intestine inflammation. Sci Adv. 2023;9(5):eadd6165.","journal-title":"Sci Adv"},{"issue":"4","key":"3733_CR215","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jasms.2003.12.006","volume":"15","author":"OK Bernhard","year":"2004","unstructured":"Bernhard OK, Cunningham AL, Sheil MM. Analysis of proteins copurifying with the CD4\/lck complex using one-dimensional polyacrylamide gel electrophoresis and mass spectrometry: comparison with affinity-tag based protein detection and evaluation of different solubilization methods. J Am Soc Mass Spectrom. 2004;15(4):558\u201367.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"8","key":"3733_CR216","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1074\/jbc.M109.035295","volume":"285","author":"J Guo","year":"2010","unstructured":"Guo J, Hong F, Loke J, Yea S, Lim CL, Lee U, et al. A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells. J Biol Chem. 2010;285(8):5428\u201337.","journal-title":"J Biol Chem"},{"issue":"12","key":"3733_CR217","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1128\/MCB.00320-12","volume":"32","author":"M Chandra","year":"2012","unstructured":"Chandra M, Zang S, Li H, Zimmerman LJ, Champer J, Tsuyada A, et al. Nuclear translocation of type I transforming growth factor beta receptor confers a novel function in RNA processing. Mol Cell Biol. 2012;32(12):2183\u201395.","journal-title":"Mol Cell Biol"},{"issue":"22","key":"3733_CR218","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1038\/onc.2016.449","volume":"36","author":"M Sarkar","year":"2017","unstructured":"Sarkar M, Khare V, Ghosh MK. The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis. Oncogene. 2017;36(22):3080\u201393.","journal-title":"Oncogene"},{"issue":"1","key":"3733_CR219","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41467-023-38605-3","volume":"14","author":"X Xiao","year":"2023","unstructured":"Xiao X, Shi J, He C, Bu X, Sun Y, Gao M, et al. ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun. 2023;14(1):2859.","journal-title":"Nat Commun"},{"issue":"1","key":"3733_CR220","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1261\/rna.035410.112","volume":"19","author":"I Evsyukova","year":"2013","unstructured":"Evsyukova I, Bradrick SS, Gregory SG, Garcia-Blanco MA. Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6. RNA. 2013;19(1):103\u201315.","journal-title":"RNA"},{"issue":"776","key":"3733_CR221","doi-asserted-by":"publisher","first-page":"eabq3362","DOI":"10.1126\/scisignal.abq3362","volume":"16","author":"Z Wang","year":"2023","unstructured":"Wang Z, Pan B, Qiu J, Zhang X, Ke X, Shen S, et al. SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in hepatocellular carcinoma cells to promote immune escape. Sci Signal. 2023;16(776):eabq3362.","journal-title":"Sci Signal"},{"issue":"1","key":"3733_CR222","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12931-022-02226-z","volume":"23","author":"K Cao","year":"2022","unstructured":"Cao K, Ling X, Jiang X, Ma J, Zhu J. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. Respir Res. 2022;23(1):306.","journal-title":"Respir Res"},{"issue":"1","key":"3733_CR223","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12935-022-02611-0","volume":"22","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Deng Z, Li Y, Wei B, Chen X, Zhao Z, et al. ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis. Cancer Cell Int. 2022;22(1):193.","journal-title":"Cancer Cell Int"},{"key":"3733_CR224","doi-asserted-by":"publisher","first-page":"5244820","DOI":"10.1155\/2022\/5244820","volume":"2022","author":"F Xu","year":"2022","unstructured":"Xu F, Xiong N, Yuan Y, Liu J. Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma. J Oncol. 2022;2022:5244820.","journal-title":"J Oncol"},{"issue":"2","key":"3733_CR225","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1021\/acs.jmedchem.8b00973","volume":"62","author":"DJ Hwang","year":"2019","unstructured":"Hwang DJ, He Y, Ponnusamy S, Mohler ML, Thiyagarajan T, McEwan IJ, et al. New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity. J Med Chem. 2019;62(2):491\u2013511.","journal-title":"J Med Chem"},{"issue":"21","key":"3733_CR226","doi-asserted-by":"publisher","first-page":"12642","DOI":"10.1021\/acs.jmedchem.0c00943","volume":"63","author":"Y He","year":"2020","unstructured":"He Y, Hwang DJ, Ponnusamy S, Thiyagarajan T, Mohler ML, Narayanan R, et al. Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer. J Med Chem. 2020;63(21):12642\u201365.","journal-title":"J Med Chem"},{"issue":"19","key":"3733_CR227","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-23-0285","volume":"83","author":"R Sun","year":"2023","unstructured":"Sun R, Yan B, Li H, Ding D, Wang L, Pang J, et al. Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis. Cancer Res. 2023;83(19):3192\u2013204.","journal-title":"Cancer Res"},{"issue":"7","key":"3733_CR228","doi-asserted-by":"publisher","first-page":"652","DOI":"10.2174\/1568009617666171107103936","volume":"18","author":"R Ge","year":"2018","unstructured":"Ge R, Xu X, Xu P, Li L, Li Z, Bian J. Degradation of Androgen Receptor through Small Molecules for Prostate Cancer. Curr Cancer Drug Targets. 2018;18(7):652\u201367.","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"3733_CR229","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1021\/jm400048v","volume":"56","author":"P Purushottamachar","year":"2013","unstructured":"Purushottamachar P, Godbole AM, Gediya LK, Martin MS, Vasaitis TS, Kwegyir-Afful AK, et al. Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer. J Med Chem. 2013;56(12):4880\u201398.","journal-title":"J Med Chem"},{"issue":"15","key":"3733_CR230","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1158\/1078-0432.CCR-14-0292","volume":"20","author":"Z Yu","year":"2014","unstructured":"Yu Z, Cai C, Gao S, Simon NI, Shen HC, Balk SP. Galeterone prevents androgen receptor binding to chromatin and enhances degradation of mutant androgen receptor. Clin Cancer Res. 2014;20(15):4075\u201385.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3733_CR231","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1158\/1078-0432.CCR-15-1432","volume":"22","author":"B Montgomery","year":"2016","unstructured":"Montgomery B, Eisenberger MA, Rettig MB, Chu F, Pili R, Stephenson JJ, et al. Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer. Clin Cancer Res. 2016;22(6):1356\u201363.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3733_CR232","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.eururo.2019.08.034","volume":"76","author":"ME Taplin","year":"2019","unstructured":"Taplin ME, Antonarakis ES, Ferrante KJ, Horgan K, Blumenstein B, Saad F, et al. Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2019;76(6):843\u201351.","journal-title":"Eur Urol"},{"issue":"11","key":"3733_CR233","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.3390\/ijms23116206","volume":"23","author":"F Li","year":"2022","unstructured":"Li F, Aljahdali IAM, Ling X. Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein-Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases. Int J Mol Sci. 2022;23(11):6206.","journal-title":"Int J Mol Sci"},{"key":"3733_CR234","doi-asserted-by":"crossref","unstructured":"Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M. FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. Int J Mol Sci. 2024;25(7):3693.","DOI":"10.3390\/ijms25073693"},{"issue":"1","key":"3733_CR235","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1038\/s41467-018-06067-7","volume":"9","author":"Q Li","year":"2018","unstructured":"Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, et al. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun. 2018;9(1):3600.","journal-title":"Nat Commun"},{"issue":"11","key":"3733_CR236","doi-asserted-by":"publisher","first-page":"101001","DOI":"10.1016\/j.jpha.2024.101001","volume":"14","author":"X Ling","year":"2024","unstructured":"Ling X, Wu W, Yan L, Curtin L, Farrauto MM, Sexton S, et al. Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer. J Pharm Anal. 2024;14(11):101001.","journal-title":"J Pharm Anal"},{"issue":"19","key":"3733_CR237","doi-asserted-by":"publisher","first-page":"7938","DOI":"10.1158\/0008-5472.CAN-08-0932","volume":"68","author":"EL Clark","year":"2008","unstructured":"Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S, et al. The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res. 2008;68(19):7938\u201346.","journal-title":"Cancer Res"},{"issue":"28","key":"3733_CR238","doi-asserted-by":"publisher","first-page":"25226","DOI":"10.18632\/oncotarget.4712","volume":"6","author":"M Wen","year":"2015","unstructured":"Wen M, Kwon Y, Wang Y, Mao JH, Wei G. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer. Oncotarget. 2015;6(28):25226\u201339.","journal-title":"Oncotarget"},{"key":"3733_CR239","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.2147\/CMAR.S157925","volume":"10","author":"L Dai","year":"2018","unstructured":"Dai L, Pan G, Liu X, Huang J, Jiang Z, Zhu X, et al. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer. Cancer Manag Res. 2018;10:1799\u2013806.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3733_CR240","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13045-018-0656-7","volume":"11","author":"M Zhang","year":"2018","unstructured":"Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan C, et al. The lncRNA NEAT1 activates Wnt\/beta-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol. 2018;11(1):113.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3733_CR241","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13046-019-1304-y","volume":"38","author":"V Khare","year":"2019","unstructured":"Khare V, Tabassum S, Chatterjee U, Chatterjee S, Ghosh MK. RNA helicase p68 deploys beta-catenin in regulating RelA\/p65 gene expression: implications in colon cancer. J Exp Clin Cancer Res. 2019;38(1):330.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"3733_CR242","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/jcmm.14038","volume":"23","author":"N Wu","year":"2019","unstructured":"Wu N, Jiang M, Han Y, Liu H, Chu Y, Liu H, et al. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5. J Cell Mol Med. 2019;23(2):1354\u201362.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"3733_CR243","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/ol.2020.12138","volume":"20","author":"X Wu","year":"2020","unstructured":"Wu X, Liu G, Liu R, He J, Wang G, Zhang H, et al. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications. Oncol Lett. 2020;20(5):275.","journal-title":"Oncol Lett"},{"issue":"4","key":"3733_CR244","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3892\/ol.2021.12975","volume":"22","author":"M Luo","year":"2021","unstructured":"Luo M, Zhou Y. Comprehensive analysis of differentially expressed genes reveals the promotive effects of UBE2T on colorectal cancer cell proliferation. Oncol Lett. 2021;22(4):714.","journal-title":"Oncol Lett"},{"issue":"2","key":"3733_CR245","doi-asserted-by":"publisher","first-page":"101493","DOI":"10.1016\/j.clinre.2020.06.018","volume":"45","author":"M Wu","year":"2021","unstructured":"Wu M, Li X, Huang W, Chen Y, Wang B, Liu X. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53. Clin Res Hepatol Gastroenterol. 2021;45(2):101493.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3733_CR246","doi-asserted-by":"publisher","first-page":"111347","DOI":"10.1016\/j.cbi.2024.111347","volume":"406","author":"B Liu","year":"2025","unstructured":"Liu B, Liu R, Zhang X, Tian L, Li Z, Yu J. Ubiquitin-conjugating enzyme E2T confers chemoresistance of colorectal cancer by enhancing the signal propagation of Wnt\/beta-catenin pathway in an ERK-dependent manner. Chem Biol Interact. 2025;406:111347.","journal-title":"Chem Biol Interact"},{"issue":"7319","key":"3733_CR247","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature09460","volume":"467","author":"PJ Campbell","year":"2010","unstructured":"Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature. 2010;467(7319):1109\u201313.","journal-title":"Nature"},{"issue":"7540","key":"3733_CR248","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495\u2013501.","journal-title":"Nature"},{"issue":"2","key":"3733_CR249","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41568-022-00530-w","volume":"23","author":"SR Hingorani","year":"2023","unstructured":"Hingorani SR. Epithelial and stromal co-evolution and complicity in pancreatic cancer. Nat Rev Cancer. 2023;23(2):57\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3733_CR250","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","volume":"22","author":"SB Dreyer","year":"2025","unstructured":"Dreyer SB, Beer P, Hingorani SR, Biankin AV. Improving outcomes of patients with pancreatic cancer. Nat Rev Clin Oncol. 2025;22(6):439\u201356.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"3733_CR251","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jclinpath-2020-207002","volume":"74","author":"M Morimachi","year":"2020","unstructured":"Morimachi M, Hirabayashi K, Takanashi Y, Kawanishi A, Saika T, Ueyama Y, et al. Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma. J Clin Pathol. 2020;74(11):741\u20135.","journal-title":"J Clin Pathol"},{"issue":"5907","key":"3733_CR252","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1126\/science.1160165","volume":"322","author":"AA Cohen","year":"2008","unstructured":"Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, Sigal A, et al. Dynamic proteomics of individual cancer cells in response to a drug. Science. 2008;322(5907):1511\u20136.","journal-title":"Science"},{"issue":"2","key":"3733_CR253","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3892\/ol.2020.11644","volume":"20","author":"YW Zheng","year":"2020","unstructured":"Zheng YW, Gao PF, Ma MZ, Chen Y, Li CY. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer. Oncol Lett. 2020;20(2):1462\u20138.","journal-title":"Oncol Lett"},{"issue":"7","key":"3733_CR254","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","volume":"64","author":"X Jiang","year":"2023","unstructured":"Jiang X, Ma Y, Wang T, Zhou H, Wang K, Shi W, et al. Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress. Gastroenterology. 2023;64(7):1232\u201347.","journal-title":"Gastroenterology"},{"key":"3733_CR255","doi-asserted-by":"crossref","unstructured":"Young EP, Marinoff AE, Lopez-Fuentes E, Sweet-Cordero EA. Osteosarcoma through the Lens of Bone Development, Signaling, and Microenvironment. Cold Spring Harb Perspect Med; 2024;14(10):a041635.","DOI":"10.1101\/cshperspect.a041635"},{"issue":"1","key":"3733_CR256","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1080\/21691401.2019.1648285","volume":"47","author":"X Chen","year":"2019","unstructured":"Chen X, Zhang C, Wang X. Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p\/DDX5 axis. Artif Cells Nanomed Biotechnol. 2019;47(1):3322\u20138.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"3733_CR257","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s13577-020-00412-z","volume":"34","author":"X Mao","year":"2021","unstructured":"Mao X, Guo S, Gao L, Li G. Circ-XPR1 promotes osteosarcoma proliferation through regulating the miR-214-5p\/DDX5 axis. Hum Cell. 2021;34(1):122\u201331.","journal-title":"Hum Cell"},{"issue":"1","key":"3733_CR258","doi-asserted-by":"publisher","first-page":"2230641","DOI":"10.1080\/15384047.2023.2230641","volume":"24","author":"S Yang","year":"2023","unstructured":"Yang S, Zhou P, Zhang L, Xie X, Zhang Y, Bo K, et al. VAMP8 suppresses the metastasis via DDX5\/beta-catenin signal pathway in osteosarcoma. Cancer Biol Ther. 2023;24(1):2230641.","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"3733_CR259","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1021\/acschembio.4c00360","volume":"19","author":"D Sun","year":"2024","unstructured":"Sun D, Kang L, Chen X, Xue J, Wu X, Wong J, et al. Identification of DDX5 as a Potential Therapeutic Target of Osteosarcoma Using Thiazolone Probes. ACS Chem Biol. 2024;19(8):1803\u201312.","journal-title":"ACS Chem Biol"},{"issue":"10","key":"3733_CR260","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1021\/pr900235t","volume":"8","author":"S Pahlich","year":"2009","unstructured":"Pahlich S, Quero L, Roschitzki B, Leemann-Zakaryan RP, Gehring H. Analysis of Ewing sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68\/72 within protein-RNA complexes. J Proteome Res. 2009;8(10):4455\u201365.","journal-title":"J Proteome Res"},{"issue":"5","key":"3733_CR261","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3727\/096504016X14685034103310","volume":"24","author":"Y Wang","year":"2016","unstructured":"Wang Y, Leng H, Chen H, Wang L, Jiang N, Huo X, et al. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K\/Akt Signaling Pathway. Oncol Res. 2016;24(5):361\u20139.","journal-title":"Oncol Res"},{"issue":"11","key":"3733_CR262","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2217\/epi-2019-0125","volume":"11","author":"L Shen","year":"2019","unstructured":"Shen L, Zhao K, Li H, Ning B, Wang W, Liu R, et al. Downregulation of UBE2T can enhance the radiosensitivity of osteosarcoma in vitro and in vivo. Epigenomics. 2019;11(11):1283\u2013305.","journal-title":"Epigenomics"},{"key":"3733_CR263","doi-asserted-by":"publisher","first-page":"1000949","DOI":"10.3389\/fonc.2023.1000949","volume":"13","author":"G Qu","year":"2023","unstructured":"Qu G, Xu Y, Qu Y, Qiu J, Chen G, Zhao N, et al. Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing\u2019s sarcoma. Front Oncol. 2023;13:1000949.","journal-title":"Front Oncol"},{"issue":"4","key":"3733_CR264","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1158\/1078-0432.CCR-23-0873","volume":"30","author":"CR Schott","year":"2024","unstructured":"Schott CR, Koehne AL, Sayles LC, Young EP, Luck C, Yu K, et al. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach. Clin Cancer Res. 2024;30(4):849\u201364.","journal-title":"Clin Cancer Res"},{"key":"3733_CR265","doi-asserted-by":"publisher","first-page":"216241","DOI":"10.1016\/j.canlet.2023.216241","volume":"565","author":"Y Shao","year":"2023","unstructured":"Shao Y, Li H, Wu Y, Wang X, Meng J, Hu Z, et al. The feedback loop of AURKA\/DDX5\/TMEM147-AS1\/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer. Cancer Lett. 2023;565:216241.","journal-title":"Cancer Lett"},{"issue":"5","key":"3733_CR266","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3892\/ol.2025.15001","volume":"29","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang W, Zheng D, Gao Y. Bone mesenchymal stem cell\u2013derived exosome\u2013encapsulated microRNA\u2013125b\u20135p inhibits ovarian cancer progression via DDX5 downregulation. Oncol Lett. 2025;29(5):255.","journal-title":"Oncol Lett"},{"issue":"1","key":"3733_CR267","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/dna.2020.5823","volume":"40","author":"R Zou","year":"2021","unstructured":"Zou R, Xu H, Li F, Wang S, Zhu L. Increased Expression of UBE2T Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of UBE2s, Clinical Samples, and the GEO Database. DNA Cell Biol. 2021;40(1):36\u201360.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"3733_CR268","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13048-022-01034-9","volume":"15","author":"P Cui","year":"2022","unstructured":"Cui P, Li H, Wang C, Liu Y, Zhang M, Yin Y, et al. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer. J Ovarian Res. 2022;15(1):103.","journal-title":"J Ovarian Res"},{"issue":"8","key":"3733_CR269","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1080\/15384101.2022.2031426","volume":"21","author":"W Huang","year":"2022","unstructured":"Huang W, Huang H, Xiao Y, Wang L, Zhang T, Fang X, et al. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT\/mTOR dependent manner in ovarian cancer. Cell Cycle. 2022;21(8):780\u201391.","journal-title":"Cell Cycle"},{"issue":"9","key":"3733_CR270","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/neuonc\/nos131","volume":"14","author":"R Wang","year":"2012","unstructured":"Wang R, Jiao Z, Li R, Yue H, Chen L. p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-kappaB transcription factor p50. Neuro Oncol. 2012;14(9):1116\u201324.","journal-title":"Neuro Oncol"},{"issue":"1","key":"3733_CR271","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/cas.13858","volume":"110","author":"R Wang","year":"2019","unstructured":"Wang R, Bao HB, Du WZ, Chen XF, Liu HL, Han DY, et al. P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5. Cancer Sci. 2019;110(1):107\u201317.","journal-title":"Cancer Sci"},{"issue":"7","key":"3733_CR272","doi-asserted-by":"publisher","first-page":"110225","DOI":"10.1016\/j.isci.2024.110225","volume":"27","author":"C Wang","year":"2024","unstructured":"Wang C, He Y, Fang X, Zhang D, Huang J, Zhao S, et al. METTL1-modulated LSM14A facilitates proliferation and migration in glioblastoma via the stabilization of DDX5. iScience. 2024;27(7):110225.","journal-title":"iScience"},{"issue":"11","key":"3733_CR273","doi-asserted-by":"publisher","first-page":"10275","DOI":"10.18632\/aging.103239","volume":"12","author":"P Huang","year":"2020","unstructured":"Huang P, Guo Y, Zhao Z, Ning W, Wang H, Gu C, et al. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT. Aging. 2020;12(11):10275\u201389.","journal-title":"Aging"},{"issue":"2","key":"3733_CR274","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/cas.15604","volume":"114","author":"X Tao","year":"2023","unstructured":"Tao X, Wu X, Zhou P, Yu X, Zhao C, Peng X, et al. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6. Cancer Sci. 2023;114(2):521\u201332.","journal-title":"Cancer Sci"},{"key":"3733_CR275","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2147\/DDDT.S405450","volume":"17","author":"Y Wang","year":"2023","unstructured":"Wang Y, Gao G, Wei X, Zhang Y, Yu J. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt\/beta-Catenin Signaling Pathway. Drug Des Devel Ther. 2023;17:1357\u201369.","journal-title":"Drug Des Devel Ther"},{"issue":"18","key":"3733_CR276","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1158\/1078-0432.CCR-25-0261","volume":"31","author":"F Zhou","year":"2025","unstructured":"Zhou F, Sun Y, Chen X, Wu D, Tao Z, Wu L, et al. UBE2T-Mediated HP1alpha Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1\/TP53-Mutant Glioma. Clin Cancer Res. 2025;31(18):3970\u201383.","journal-title":"Clin Cancer Res"},{"key":"3733_CR277","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-015-0275-x","volume":"34","author":"D Westover","year":"2015","unstructured":"Westover D, Li F. New trends for overcoming ABCG2\/BCRP-mediated resistance to cancer therapies. J Exp Clin Cancer Res. 2015;34:159.","journal-title":"J Exp Clin Cancer Res"},{"key":"3733_CR278","doi-asserted-by":"crossref","unstructured":"Serra M, Hattinger CM, Pasello M, Casotti C, Fantoni L, Riganti C et al. Impact of ABC Transporters in Osteosarcoma and Ewing\u2019s Sarcoma: Which Are Involved in Chemoresistance and Which Are. Not? Cells. 2021;10(9):2461.","DOI":"10.3390\/cells10092461"},{"key":"3733_CR279","doi-asserted-by":"crossref","unstructured":"Raguz M, Tarle M, Muller D, Tomasovic-Loncaric C, Chudy H, Marinovic T et al. ABCG2 Expression as a Potential Survival Predictor in Human Gliomas. Int J Mol Sci. 2024;25(6):3116.","DOI":"10.3390\/ijms25063116"},{"key":"3733_CR280","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-015-0362-9","volume":"14","author":"D Westover","year":"2015","unstructured":"Westover D, Ling X, Lam H, Welch J, Jin C, Gongora C, et al. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance. Mol Cancer. 2015;14:92.","journal-title":"Mol Cancer"},{"issue":"10","key":"3733_CR281","first-page":"1765","volume":"7","author":"X Ling","year":"2015","unstructured":"Ling X, Liu X, Zhong K, Smith N, Prey J, Li F. FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models. Am J Transl Res. 2015;7(10):1765\u201381.","journal-title":"Am J Transl Res"},{"issue":"1","key":"3733_CR282","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13046-021-02026-1","volume":"40","author":"F Li","year":"2021","unstructured":"Li F, Aljahdali IAM, Zhang R, Nastiuk KL, Krolewski JJ, Ling X. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1alpha, HIF2alpha, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma. J Exp Clin Cancer Res. 2021;40(1):254.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"3733_CR283","first-page":"1765","volume":"7","author":"X Ling","year":"2015","unstructured":"Ling X, Liu XJ, Zhong K, Smith N, Prey J, Li F. FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models. Am J Transl Res. 2015;7(10):1765\u201381.","journal-title":"Am J Transl Res"},{"issue":"5","key":"3733_CR284","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cvr\/cvx025","volume":"113","author":"Y Fan","year":"2017","unstructured":"Fan Y, Zhang J, Chen CY, Xiao YB, Asico LD, Jose PA, et al. Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis. Cardiovascular Res. 2017;113(5):519\u201330.","journal-title":"Cardiovascular Res"},{"issue":"8","key":"3733_CR285","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.7150\/thno.18407","volume":"7","author":"DJ Son","year":"2017","unstructured":"Son DJ, Jung YY, Seo YS, Park H, Lee DH, Kim S, et al. Interleukin-32alpha Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis. Theranostics. 2017;7(8):2186\u2013203.","journal-title":"Theranostics"},{"issue":"3","key":"3733_CR286","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/2211-5463.13092","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, Guo JR, Wu XL, Wang X, Zhu ZM, Wang Y, et al. TWIST1 induces phenotypic switching of vascular smooth muscle cells by downregulating p68 and microRNA-143\/145. FEBS Open Bio. 2021;11(3):932\u201343.","journal-title":"FEBS Open Bio"},{"issue":"2","key":"3733_CR287","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yexcr.2018.03.003","volume":"366","author":"W Zhao","year":"2018","unstructured":"Zhao W, Wang Z, Sun Z, He Y, Jian D, Hu X, et al. RNA helicase DDX5 participates in oxLDL-induced macrophage scavenger receptor 1 expression by suppressing mRNA degradation. Exp Cell Res. 2018;366(2):114\u201320.","journal-title":"Exp Cell Res"},{"issue":"2","key":"3733_CR288","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s40200-024-01482-8","volume":"23","author":"N Saki","year":"2024","unstructured":"Saki N, Haybar H, Maniati M, Davari N, Javan M, Moghimian-Boroujeni B. Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process. J Diabetes Metab Disord. 2024;23(2):1687\u201397.","journal-title":"J Diabetes Metab Disord"},{"issue":"11","key":"3733_CR289","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.tem.2024.04.009","volume":"35","author":"R Xu","year":"2024","unstructured":"Xu R, Vujic N, Bianco V, Reinisch I, Kratky D, Krstic J, et al. Lipid-associated macrophages between aggravation and alleviation of metabolic diseases. Trends Endocrinol Metab. 2024;35(11):981\u201395.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"3733_CR290","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/MOL.0000000000000987","volume":"36","author":"I Little","year":"2025","unstructured":"Little I, Bersie S, Redente EF, McCubbrey AL, Tarling EJ. Alveolar macrophages: guardians of the alveolar lipid galaxy. Curr Opin Lipidol. 2025;36(3):153\u201362.","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"3733_CR291","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.celrep.2014.05.019","volume":"7","author":"A Mazurek","year":"2014","unstructured":"Mazurek A, Park Y, Miething C, Wilkinson JE, Gillis J, Lowe SW, et al. Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5. Cell Rep. 2014;7(6):1887\u201399.","journal-title":"Cell Rep"},{"issue":"24","key":"3733_CR292","doi-asserted-by":"publisher","first-page":"16888","DOI":"10.1021\/acs.jmedchem.3c01589","volume":"66","author":"W Wang","year":"2023","unstructured":"Wang W, Ling X, Wang R, Xiong H, Hu L, Yang Z, et al. Structure-Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity. J Med Chem. 2023;66(24):16888\u2013916.","journal-title":"J Med Chem"},{"key":"3733_CR293","doi-asserted-by":"publisher","first-page":"117143","DOI":"10.1016\/j.ejmech.2024.117143","volume":"283","author":"W Wang","year":"2025","unstructured":"Wang W, Wang R, An L, Li L, Xiong H, Li D, et al. Design, synthesis and investigation of biological activity and mechanism of fluoroaryl-substituted derivatives at the FL118 position 7. Eur J Med Chem. 2025;283:117143.","journal-title":"Eur J Med Chem"},{"issue":"6","key":"3733_CR294","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ccell.2014.10.005","volume":"26","author":"C Sourbier","year":"2014","unstructured":"Sourbier C, Ricketts CJ, Matsumoto S, Crooks DR, Liao PJ, Mannes PZ, et al. Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer. Cancer Cell. 2014;26(6):840\u201350.","journal-title":"Cancer Cell"},{"issue":"1","key":"3733_CR295","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13046-025-03547-9","volume":"44","author":"IAM Aljahdali","year":"2025","unstructured":"Aljahdali IAM, Ling X, Wu W, Wang W, Li D, Zhang R, et al. FL496, an FL118-derived small molecule, induces growth inhibition, senescence, and apoptosis of malignant pleural mesothelioma (MPM) cells, and exhibits anti-MPM tumor efficacy strikingly superior to the pemetrexed-cisplatin combination. J Exp Clin Cancer Res. 2025;44(1):293.","journal-title":"J Exp Clin Cancer Res"},{"issue":"24","key":"3733_CR296","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.1158\/0008-5472.CAN-14-0683","volume":"74","author":"X Ling","year":"2014","unstructured":"Ling X, Xu C, Fan C, Zhong K, Li F, Wang X. FL118 Induces p53-Dependent Senescence in Colorectal Cancer Cells by Promoting Degradation of MdmX. Cancer Res. 2014;74(24):7487\u201397.","journal-title":"Cancer Res"},{"key":"3733_CR297","doi-asserted-by":"crossref","unstructured":"Wang W, Li L, Lei J, Zhang Q, Mao Z, Yang Z et al. Design and Synthesis of Novel Dual Fluoro-Substituted 10,11-Methylenedioxy-pyrrolo[3,4-b]quinoline Alkaloid Analogs as Topo I\/DDX5 Inhibitors for Colorectal Cancer. J Med Chem. 2026;69(2):1473\u2013506.","DOI":"10.1021\/acs.jmedchem.5c02967"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03733-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03733-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03733-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:01:59Z","timestamp":1783648919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03733-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":297,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3733"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03733-3","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review article contains both animal model data and human cancer cell line data. The animal model work was performed under the IACUC-approved protocol (1192\u00a0M) and the other in vitro work for the ethics approval are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The data provided in this review article are from the Authors\u2019 research team and all authors agree to publish these data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FL118 and its core structure-based analogues will be further developed in Canget BioTekpharma LLC (www.canget-biotek.com), a Roswell Park Comprehensive Cancer Center (www.roswellpark.org) spinoff company. FL and XL are two of the eighteen initial investors to develop FL118 and its core structure-relevant anticancer agents. Other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}